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ABSTRACT 
Adenylosuccinate synthetase catalyzes the first committed step in de novo 
biosyntheses of AMP from IMP and aspartate, using GTP as the energy source. Metal 
cations, ligand-induced conformational transitions and metabolic effectors significantly 
influence the catalytic potential of the synthetase. The Mg"*, Mn^*, or Ca^" bind to the same 
site, coordinating a-. P-, and y-phosphoryl groups of GTP. The level of catalysis supported 
by each cation is linked to its influence on the basicity of Asp 13, a residue which abstracts 
the proton from N1 of IMP. Zn**, a potent inhibitor of the synthetase, coordinates the P- and 
y-phosphoryl groups of GTP and His4I, stabilizing a dead-end complex of the synthetase. 
The role of metal cations in the synthetase and the related G-proteins contrasts sharply. 
Hydrogen bond formation between the 5'-phosphate of IMP and Asn38 drives large 
conformational changes as far as 30 A away. Indeed the 5'-phosphoryl group of IMP, even 
though it is not directly involves in catalysis, is as important to the stability of the transition 
state as essential protein side chains directly involved with catalysis. Guanosine 5'-
diphosphate 3 "-diphosphate (ppGpp), a pleiotropic effector of the stringent response, potently 
inhibits the synthetase. The combination of ppGpp with crystals of the synthetase, however, 
reveals guanosine 5'-diphosphate 2':3'-cyclic monophosphate, at the GTP pocket. The 
sythetase itself may catalyze the formation of the cyclic inhibitor, leading to a tight ligand-
enzyme complex. In fact, stringent effectors could modulate synthetase activity by way of 
several mechanisms, including the formation of a 6-phosphoryl-IMP and cyclic nucleotide 
complex. 
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CHAPTER 1. INTRODUCTION 
Adenylosuccinate synthetase [IMP:L-asptartate ligase (GDP), EC 6.3.4.4] catalyzes 
the reaction: 
IMP + Aspartate + GTP < > Adenylosuccinate + GDP + Pi 
This reaction is the first committed step in the conversion of IMP to AMP and represents a 
branch point of the synthesis of IMP (Figure 1), the end product of de novo purine 
biosynthesis (Stayton et al., 1983). The reaction was first shown to occur in rabbit bone 
marrow by Abrams and Bently in 1955. Lieberman (1956) demonstrated that the reaction 
occurred in Escherichia coli, then Carter and Cohen (1955, 1956) found the same reaction in 
yeast extracts. Adenylosuccinate synthetase is also involved in the purine nucleotide cycle 
(Braunstein. 1957; Lowenstein, 1972). The three enzymes adenylosuccinate synthetase, 
adenylosuccinate lyase, and AMP deaminase, carry out a net reaction 
Aspartate + GTP +H2O => Fumarate +GDP + Pi + NH3 
The operation of this cycle has been shown in mammalian muscle (Lowenstein, 1972), brain 
(Schultz et al., 1976), and kidney (Bogusky et al., 1976). It is an alternative to glutamate 
dehydrogenase for allowing release of ammonia (Stayton et al., 1983). 
Adenylosuccinate formed by adenylosuccinate synthetase is cleaved by 
adenylosuccinate lyase to form AMP (Figure 1). Adenylosuccinate synthetase activity has 
been observed in almost all tissues examined, such as bacteria, plants, and animals (Stayton 
et al., 1983). The only exception is the human erythrocyte (Lowy et al., 1970). The 
synthetase exists as both monomers and dimers (Wang et al., 1997; Stayton et al., 1983). 
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Figure 1. Conversions of IMP to AMP or GMP 
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The pH optimums for the enzyme from various sources are broad ranging from pH 6.5 to 7.5. 
Recently, cDNA sequences encoding adenylosuccinate synthetase have been cloned from 
many sources (Mantsala et al.. 1992; Wiesmuller et al., 1991; Wolfe et al., 1988; Powell et 
al., 1992; Guicheirt et al., 1991; Guicheirt et al., 1994; Fleischmann et al., 1995; Schabes et 
al., 1993; Bouyoub et al., 1996). The sequences show 40-90% identity using BESTFIT 
analysis of the GCG computer program, indicating a strong tendency to preserve a primordial 
gene throughout evolution (Bouyoub et. al. 1996). 
The substrate binding sites of adenylosuccinate synthetase are quite specific, as might 
be expected for an enzyme at a regulatory point in the purine metabolism (Stayton et al., 
1983). Hydroxylamine is the only known compound that synthetase will substitute to a 
significant degree for aspartate, and forms 6-N-hydroxyI-AMP as a product (Lieberman, 
1956). Replacement of GTP by dGTP gave approximately 40% of standard reaction rate 
(Muirhead et al., 1974). When GTPyS replaced GTP in the reaction mixture, a 12.5-foId 
decrease in maximum rate was observed (Magiaire et al., 1972). Several IMP analogs with N, 
S, and C atoms substituting for one of the phcsphoryl oxygens are also weak substrates 
(Hampton et al., 1970). 2'- dIMP and (3-D-arabinosyl-IMP were found to be substrates in 
rabbit skeletal muscle synthetase (Spector et al., 1976). 
Adenylosuccinate synthetase is potentially a target of a natural herbicide (Heim et al., 
1995) and of a drug used in the treatment of pediatric leukemia (DeAbreu et al., 1995). The 
inhibitor discovery could also support efforts in the design of drugs against HIV and cancer 
(Ahluwalia et al., 1987). It appears that synthetase is subject to feedback and product 
Inhibition by AMP, adenylosuccinate, GDP, and GMP. The KjS for AMP range from 10 to 
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3000 laM (Wyngaarden et al., 1963; Ishii et al., 1970; Clark et al., 1976; Van der Weyden et 
al., 1974). GDP and GMP have the same s range from 5 to 30 nM (Rudolph et al., 1969; 
Bishop et al., 1975; Ishii et al., 1970; Clark et al.. 1976). Adenylosuccinate, also a strong 
inhibitor, has a samilar to GDP and GMP but adenylosuccinate competes only with IMP 
not with aspartate (Rudolph et al., 1969; Spector et al., 1976; Clark et al., 1976). Some anions 
have also been shown to inhibit synthetase, including NO,', SCN", CI", I", Br", and HCO," 
(Markham et al., 1977; Bishop et al., 1975; Muirhead et al., 1974; Markham et al., 1977). 
NO," has been shown to be a synergistic inhibitor with GDP (Markham et al., 1977, 1975) 
and binds to the same site as the y-phosphate of GTP. Hadacidin, alanosine, and succinate 
resemble aspartate (Kackza et al., 1962; Gale et al., 1968). Both hadacidin and alanosine have 
low K,'s, however only hadacidin is competitive with respect to aspartate (Markham et al., 
1977; Fisher 1979). Alanosine is believed to inhibit synthetase through alanosyl-5-amino-4-
imidazole carboxylic acid ribonucleotide (alanosyl-AICOR) which is competitive with 
respect to IMP (Tyagi et al.. 1980). Succinate is a competitive inhibitor with respect to 
aspartate. 6-mercaptopurine ribonucleotide is a competitive inhibitor to IMP with a relatively 
low K, (~10 |iM) (Clark et al., 1976). (+)-Hydantocidin is a recently discovered natural 
spironucleoside from Streptomyces hygroscopicus with potent herbicidal activity (Haruyama 
et al., 1991; Nakajima et al., 1991). Hydantocidin 5'-monophosphate inhibits the synthetase 
as an analog of IMP (Fonne-Pfister et al., 1996; Poland et al., 1996c). 
Adenylosuccinate synthetase catalyzes the synthesis of carbon-nitrogen bonds 
coupled to nucleoside triphosphate hydrolysis. During the catalysis the C-6 oxygen of IMP is 
quantitatively transferred to the released Pj from GTP (Lieberman, 1956). The question of 
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whether the interaction between IMP and the y-phosphoryl of GTP occurs before, during, or 
after the amino nitrogen of aspartate attacks the C-6 position of IMP has lead to three 
proposed reaction mechanisms for the synthetase (Stayton et al., 1983). The first mechanism 
which enjoys considerable supports in the literature is a two-step process (Figure 2): (I) the 
transfer of the y-phosphate of GTP to the 6-oxygen of IMP to form a 6-phosphoryl-IMP 
intermediate and (2) the nucleophilic displacement of the 6-phosphate group by aspartate 
(Lieberman, 1956; Fromm, 1958; Bass et al., 1984). In the second mechanism, there is a 
concerted reaction with all the substrates participating simultaneously (Miller & Buchannan, 
1962). On the other hand, the third mechanism suggests that the amino nitrogen of aspartate 
attacks the C-6 position of IMP, thereby activating the oxygen atom for attack on the y-
phosphate of GTP. This mechanism proposed by Markham and Reed (1978) for the A. 
vinelandii enzyme based on GTP analogue studies, and may be valid for those analogues. 
The more recent supports for the first mechanism were obtained from the results of positional 
isotope exchange, isotope exchange at equilibrium, and crystal structure studies. Bass et al. 
(1984) demonstrated that the P-y bridge oxygen of GTP is exchanged in the absence of 
aspartate. The positional exchange occurs only by cleavage of that bond, suggesting the 
phosphoryl transfer to IMP can precede the binding of the aspartate. The equilibrium isotope 
exchange (Cooper et al., 1986) showed that the exchanges of GTP with both GDP and Pj, 
IMP with adenylosuccinate were at the similar rate but aspartate exchanged with 
adenylosuccinate at a higher rate. The slower IMP and GTP exchange rates suggest a forward 
binding mechanism containing a preferred path in which the quaternary complex is most 
often formed by aspartate binding to the E-GTP-IMP complex. When the synthetase is 
6-phosphoryl-IMP 
+ "a" Mg 
2+ 
OH OH 
i-
i-
OH OR 
6-phosphoryl-lMP Aspartate Adenylosuccinate Phosphate 
Figure 2. Tlie two step reaction mechanism 
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crystallized in the presence of GTP, Mg^", hadacidin, and either IMP or 6-mercapto-IMP, 6-
phosphoryl-IMP or 6-thiophosphoryl-IMP has been found in the active site of the crystalline 
synthetase (Poland et al., 1997). The 6-phosphoryl-IMP intermediate must be tightly bound 
in the active site and/or very unstable in bulk solution since it has never been isolated and 
synthesized. Various studies have been performed concerning the binding mechanism of the 
substrates. It is generally agreed upon that the binding mechanism is a random Ter Ter 
(Stayton et al., 1983; Rudolph et al., 1969). 
It is evident that activity of the synthetase in cell is highly regulated. The control of 
adenylosuccinate synthetase can be implemented at several levels, such as substrate 
availability, feedback inhibition, stringent response, and transcriptional regulation by PurR 
repressor using ATP as the copressor (Stayton et al., 1983). One striking feature of the two 
biosynthetic pathways leading from IMP is the requirement for ATP as a cofactor in 
guanylate synthesis and the reciprocal requirement for GTP as a cofactor in adenylate 
synthesis. This phenomenon has been suggested as one mechanism by which the appropriate 
ATP/GTP ratio is maintained (Magasanik, 1962). Adenylosuccinate synthetase is subject to 
inhibition by the products of its reaction and by various substrate analogs. E. coli synthetase 
is roughly inhibited by purine nucleotides with little specificity. Recently, based on the initial 
kinetic and site-mutagenesis data, Wang et al. (1997) speculated that the ligand-induced 
dimerization may be also a regulation mechanism for the synthetase. Adenylosuccinate 
synthetase and IMP dehydrogenase are involved in the stringent control system. Stringent 
response is mediated by a family of guanine nucleotides including guanosine 5'-diphosphate-
3'-diphosphate (ppGpp) (Cashel, M., 1975, 1996). One characteristic of the stringent 
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response is a reduction in the rate of purine nucleotide synthesis and a decrease in the ATP 
and GTP pool sizes (Gallant et al., 1971). ppGpp potently inhibits adenylosuccinate 
synthetase (apparent Ki = 50 ^M) and IMP dehydrogenase. The mechanism of inhibition to 
the synthetase by ppGpp, however, remains a point of controversy. ppGpp may inhibit the 
synthetase by binding to an allosteric site, as suggested by its noncompetitive inhibition with 
respect to GTP (Gallant et al., 1971), by simply binding to the GTP pocket, as suggested by 
its competitive inhibition with respect to GTP in a different study (Stayton et al., 1979). 
Crystal structure studies were conducted to identify the ppGpp binding site in the synthetase. 
The resulting structures reveal that the electron density at the GTP pocket which is consistent 
with guanosine 5'-diphosphate 2':3'-cyclic monophosphate (ppG2':3'p), suggesting that 
ppG2':3'p may be another effector involved in the stringent response. 
Unligated and ligated crystal structures of adenylosuccinate synthetase fi-om E. coli 
have been solved recently (Poland et al., 1993, 1996, 1997; Silva et al., 1995). The synthetase 
adopts a polypeptide fold similar to that of dethiobiotin synthetase firom E. coli, an enzyme 
that couples the hydrolysis of ATP in the conversion of 7,8-diaminopelargonic acid to 
dethiobiotin (Huang et al., 1994). Although the folding topologies of the E. coli synthetase 
are significantly different firom those of the p21 ras proteins, residues that interact with GTP 
in the p21 ras proteins are present in the synthetase in the nearly identical positions. The 
synthetase contains amino acid sequences in its GTP-binding domain that are homologous to 
the G-proteins (Poland et al., 1993, 1995; Bourne et al., 1991; Dever et al., 1987). This 
homology includes a glycine-rich phosphate-binding loop (p-loop, G1-region), GXXXXGK, 
and a guanine-specific binding region (G4-region), (N/T/Q)KXD. However, the consensus 
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sequences which are involved in the recognition of the metal ion in the G-protein are absent 
from the synthetase family. 
Although the common Mg^* binding elements of G-protein are missed in the 
synthetase, the synthetase from all sources requires divalent metal cations for its activity. 
Magnesium is the best activator, and Mn^^ and Ca^* will substitute with decreased activity. In 
contrast. Zn** is a potent inhibitor for the synthetase (Stayton et al., 1983; Kang et al., 1995). 
The studies of interaction of manganese with the A. vinelandii synthetase showed that the 
enzyme did not seem to bind Mg^* or Mn"* at a distinct site consistent with the role of the 
metal as a chelator of the substrate GTP (Markham. 1977; Markham et al., 1978). Kang et al. 
(1995) demonstrated that the E. coli synthetase requires two metal ions for its full activity. 
The crystal structures of the synthetase complexes (Poland et al., 1996) identified the Mg'* 
binding site which is strikingly different from that in the G-proteins. To understand the 
functions of the divalent metal cation, we will present crystal structures of the synthetase 
complexed with various metal ions. 
Ligand-induced conformational changes and reorganization of the active site are 
another well-documented phenomenon in enzymology. Structural comparison between the 
unligated and the fully ligated synthetase (synthetase complexed with GDP, IMP, Hadacidin, 
NOj", and Mg^*) reveals that the loop 42-53 (40s loop) undergoes up to 9 A relocation toward 
the guanine nucleotide. After the conformational change, the backbone carbonyl group of 
GIy40 coordinates to bound Mg^*; the backbone amide group of Thr 42 hydrogen bonds to 
the a-phosphate group of GDP; the side-chain of His 41 interacts with the P-phosphate group 
of GDP; 5"-phosphate of IMP interacts with the side chain of Asn38. The ligand-enzyme 
10 
interactions, however, which contribute most (in terms of a thermodynamic driving force) to 
this conformational change have yet to be identified. Poland et al. (1996a) found that the 
phosphate moiety of guanine nucleotide is not recognized by the synthetase in the absence of 
other substrates. Furthermore, when guanine nucleotides are infused into the unligated crystal 
synthetase in P2,2,2, form, the synthetase does not undergo a conformational change in 
response to the binding of guanine nucleotides. On the other hand, the literature has 
suggested that 5'-phosphate group of IMP is essential for catalytic activity of the synthetase. 
IMP analogs, in which one phosphate oxygen of IMP was replaced by another atom, 
significantly reduce the reaction efficiency (Hampton et al., 1970). Recently, Wang et al. 
(1998) found that mutation of Asn38 to Ala lower enzyme 200-fold, but have no 
influence in for all three substrates. Consistent with the kinetic data, we found IMP plays 
an essential role in active site construction of the synthetase. 
Dissertation Organization 
This dissertation is presented as three journal papers followed by a general conclusion 
chapter. The references cited in the general introduction and general conclusion are listed 
after the general conclusion chapter. 
Chapter 1 presents the crystal structures of adenylosuccinate synthetase from E. coli 
complexed with various metal cations. Our results show that the synthetase and G-proteins 
recognize the catalytic divalent metal cations in a significantly different way. Furthermore, 
Zn^", a potent inhibitor, binds the site of adenylosuccinate synthetase corresponding 
structurally to the Mg^' site of G-proteins. 
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Chapter 2 is the crystal structure study of conformational changes of the loop 42-53 
in response to ligation. Data demonstrate that IMP alone can organize the active site of the 
synthetase. 
Chapter 3 reports the first crystal structure of a stringent response effector (guanosine 
5"-diphosphate-2\3'-monophosphate) complexed with target enzyme, adenylosuccinate 
synthetase. 
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CHAPTER 2. DISTINCT SITES FOR DIVALENT CATION ACTIVATION AND 
INHIBITION OF ADENYLOSUCCINATE SYNTHETASE FROM Escherichia coli 
A paper to be submitted to Biochemistry 
Zhenglin Hou, Herbert J. Fromm and Richard B. Honzatko 
Abstract 
Adenylosuccinate synthetase is a metal-dependent, GTP hydrolase which governs the 
first committed step in the biosynthesis of AMP. Crystalline complexes of adenylosuccinate 
synthetase with substrates, substrate analogs and divalent cations reveal a common, primary 
binding site for Mg*^. Mn^* and Ca**, and a distinct binding site for Zn"* in the presence of 
Mg'*. The side chain of Asp 13. a putative catalytic base, is in the inner sphere of the cation 
in the Ca"* and Mn"* complexes, but not in the Mg^* complex. Hence the reduction in 
synthetase activity when Ca** or Mn"' is used in place of Mg*' may arise from the reduced 
basicity of a metal-coordinated Asp 13. Zn"*. in the presence of Mg*", interacts at a distinct 
site and stabilizes a dead-end complex which does not lead to the formation of 6-phosphoryl-
IMP. The Zn'* site of adenylosuccinate synthetase corresponds structurally to the Mg"' site 
of G-proteins, and to a Mg^* site in dethiobiotin synthetase. Efforts to locate a low affinity 
site for Mg*' resulted in the first crystalline complex of the synthetase with L-aspartate. The 
L-aspartate complex does not reveal a secondary site for Mg**, but suggests a mechanism 
whereby bonding energy, derived from interactions of the a-carboxylate of L-aspartate, 
compress the a-amino group of that substrate into the base moiety IMP. 
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Introduction 
Approximately one-third of all proteins and enzymes purified to apparent 
homogeneity require metal ions as cofactors for biological ftmction (Holm et al., 1996). 
Metal ions stabilize protein tertiary and/or quaternary structure and are cofactors in substrate 
binding, activation and turnover. Adenylosuccinate synthetase [IMP:L-aspartate ligase 
(GDP-forming), EC 6.3.4.4] requires Mg^* in catalyzing the first committed step in de novo 
AMP synthesis: 
Mg^^ 
IMP + L-aspartate + GTP < • adenylosuccinate + GDP + Pi 
The catalytic mechanism is a two-step process (Poland et ai, 1997; Lieberman, 1956; 
Fromm, 1958): the formation of 6-phosphoryI-IMP by nucleophilic attack of the 6-oxo group 
of IMP on y-phosphate group of GTP, followed by the nucleophilic displacement of the 6-
phosphoryl group by L-aspartate to form adenylosuccinate. 
Although previous ligand complexes of the synthetase reveal Mg^* at the active site in 
association with GDP, hadacidin (an analog of L-aspartate), and 6-phosphoryl-IMP (Poland et 
ai, 1996), many issues regarding the mechanisms by which divalent cations influence 
synthetase activity are unresolved. Mn"* and Ca"* support catalysis by the synthetase, but at a 
rate 20-fold less than that supported by Mg^*. The structural basis for the reduced catalytic 
rate is unknown. Given the catalytic mechanism proposed for the synthetase, however, rates 
of reaction should be sensitive to the distance of separation between the divalent cation and 
the side chain of Asp 13, the putative catalytic base in the abstraction of the proton fi-om N1 
of IMP (Poland et ai, 1996, 1997). Substitution of cations with larger radii than that of Mg^* 
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could result in the coordination of Aspl 3 to the divalent cation and a concomitant reduction 
in basicity of the side chain. Zn^*. however, has an ionic radius less than that of or Ca^". 
Hence on the basis of ionic radius alone, Zn^^ should be more effective than Mn^" or Ca^" in 
supporting catalysis, yet it is one of the most potent known inhibitors of the synthetase [AT/ ~ 
30 nM, (Kang et al., 1995)]. Finally studies of initial rate kinetics indicate two Mg*" 
participate in the rate-limiting step (Kang et ai, 1995). One Mg^* putatively associates with 
GTP (the primary site), whereas the second Mg^* putaively associates with L-aspartate (the 
secondary, low affinity site). Up to concentrations of 100 mM magnesium nitrate in a buffers 
that do not compete for the pool of free Mg^", crystal structures have revealed, however, only 
the primary Mg^' site associated with the guanine nucleotide (Poland et al., 1996). 
Presented below are structures of several cation complexes of adenylosuccinate 
synthetase. Ca'* and Mn"* in the absence of Mg"* occupy the primary binding site for Mg"* 
and coordinate the side chain of Asp 13. Zn"*, however, binds in the presence of Mg*" to a 
distinct site, analogous to the Mg** binding site of G-proteins, stabilizing a dead-end complex 
that blocks the formation of 6-phosphoryl-IMP. Complexes of the synthetase in the presence 
of 300 mM Mg** and hadacidin or L -aspartate did not reveal the putative secondary binding 
site for Mg**, but suggest an important role for binding interactions of the a-carboxylate of L-
apartate in compressing its amino group into the base of IMP. 
Materials and Methods 
Purification of enzyme fi-om E. coli— The synthetase was prepared as described 
previously from a genetically engineered strain of £. coli (Wang et a., 1998). En2yme used 
in crystallization experiments was 95% pure as determined by SDS-PAGE. 
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Materials and crystallization— Hadacidin was a generous gift of Drs. Fred Rudolph 
and Bruce Cooper, Department of Biochemistry and Cell Biology, Rice University. All other 
reagents came from Sigma. Crystals were grown by the method of hanging drops under 
conditions similar to those reported previously (Poland et al., 1996). Crystals of the Zn^* 
complex formed from droplets containing 4 ^iL of enzyme solution [ HEPES (30 mM), GDP 
(4 mM), IMP (4 mM), hadacidin (4 mM), ZnCl, (2 mM), and protein (18 mg/ml) at pH 6.8] 
and 4 |iL of a crystallization buffer [polyethylene glycol 8000 (16% w/v), cacodylic 
acid/sodium cacodylate (pH 6.5, 100 mM), magnesium acetate (300 mM) and ZnCl, (2 
mM)]. The final pH of the crystallization buffer was 6.5. Wells contained 500 (iL of 
crystallization buffer. Crystals of the Ca** and Mn^* complexes employed the conditions 
above, but with the omission of ZnClj and the replacement of magnesium acetate with 
calcium or manganese acetate. The 1-aspartate complex employed the above conditions save 
with the replacement of hadacidin (an aspartate analog) with 30 mM L-aspartate and with the 
replacement of magnesium acetate with Mg(N03)2. In addition, the I-aspartate complex 
employed HEPES buffer (pH 7.7, 100 mM) to replace the cacodylic acid/sodium cacodylate 
(pH 6.5) used in other complexes. Crystals of at least 0.5 mm in all dimensions and 
belonging to the space group grew in about 1 week. All four crystalline complexes are 
isomophous, the asymmetric unit consisting of a monomer of the synthetase dimer. 
Data collection and reduction— Data from single crystals were collected on a 
Siemens area detector at 100 K and were reduced by using XENGEN (Howard et al., 1985). 
Model refinement— Starting phases were calculated from the NO," complex (Poland 
et al.. 1996), omitting all the ligands as well as the solvent structure. The ligand models were 
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fit to the electron density map, followed by a cycle of refinement using XPLOR (Briinger, 
1992). Constants of force and geometry for the protein came from Engh & Huber (1991). 
As data from the L-aspartate complex exhibited significant anisotropy in resolution, an 
overall anisotropic scale factor was employed in the refinement. In early rounds of 
refinement, all the crystal structures were heated to 2000 FC and then cooled in steps of 25-
300 K. In later rounds of refinement, the systems were heated to 1000 to 1500 K., but then 
cooled in steps of 10 K. After the slow cooling protocol was completed (at 300 K), the 
models were subject to 120 steps of conjugated gradient minimization, followed by 20 steps 
of individual B-parameter refinement. Individual B-parameters were subject to the following 
restraints: nearest neighbor, main chain atoms, 1.5 A^; next to nearest neighbor, main chain 
atoms. 2.0 A*; nearest neighbor, side chain atoms, 2.0 A*; and next to nearest neighbor, side 
chain atoms, 2.5 A'. 
Water molecules were added if (1) electron density at a level 2.5c7 was present in maps 
based on Fourier coefficients {IFobsl - l^calcD^^Pi^^c^c) (") acceptable hydrogen bonds 
could be made to an existing atom of the model. If after refinement a site of a water 
molecule fell beyond 3.3 A from its nearest neighbor, that site was omitted from the model. 
In addition, water molecules were deleted from the model if the thermal parameters exceeded 
80 A". Harmonic restraints (50 kcal/mol) were placed on the positions of the oxygen atoms of 
the water molecules to allow new water molecules to relaxed by adjustments in orientation. 
Parameters for the occupancy of solvent sites were not refined because of the high correlation 
between occupancy and thermal parameters for data to 2.5 A nominal resolution. Thus 
solvent sites with B values between 50 and 80 A^ probably represent water molecules with 
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occupancy parameters below 1.0 and thermal parameters substantially lower than reported 
from the refinement. Loop 299—304 was refined as a pair of alternate conformers, in the 
presence and absence of 1-aspartate. Atoms for each conformer of loop 299—304 and for the 
bound L-aspartate molecule were assigned occupancy parameters of 0.5. 
Results 
Overview of adenylosuccinate synthetase cation complexes— The models reported 
here will be deposited with the Protein Data Bank, Brookhaven National Laboratory. The 
method of Luzzati (1956) indicates an uncertainty in coordinates of 0.3 A. The amino acid 
sequence used in refinement is identical to that of previous work (Poland et al., 1996; Silva et 
al, 1995). Results of data collection and refinement are in Table 1. The names used here for 
the complexes (Ca*"-complex, Mn^*-complex, Zn**-Mg**-complex, and Mg*^-L-aspartate 
complex) omit explicit reference to several of the ligands bound to the active site. A 
complete list of bound ligands for each complex appears in Table 2. 
As in the other crystal forms of the synthetase, the most significant outlier in the 
Ramachandran plot is Gin 10, which exists in the same conformation in all reported structures 
of the synthetase (Poland et al., 1993, 1996, 1997; Silva et al., 1995). On the basis of 
PROCHECK (Laskowski et al., 1993) all models presented here have stereochemistry better 
than is typical for a structure of 2.5 A resolution. The Mg"*-hadacidin complex (Hou, Cashel, 
Fromm & Honzatko, unpublished data) provided data of higher resolution (2.2 A) than that of 
the Mg^*-L-aspartate complex (3.0 A) largely because of increased disorder in loop 299-304 
of the latter complex, which introduces significant anisotropy in the resolution of 
crystallographic data. The crystal structure of an Arg303-»Leu mutant, which does not bind 
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hadacidin and also has a poorly ordered loop 299—304, exhibits significant anisotropy as well 
(Choe, Poland & Honzatko, unpublished data). Refinement of an overall anisotropic scale 
factor, relating observed and calculated amplitudes of structure factors, resulted in significant 
improvement in refinement statistics (-4% and -2% reduction in and R-factor, 
respectively). 
A simplified view of one monomer of the synthetase dimer appears in Figure 1. The 
structures below are similar in conformation to previous complexes of the synthetase (Poland 
et al., 1996. 1997). Hence the focus here is on conformational differences, specifically in the 
region of bound metal ions and the bound amino acid substrate. 
Primary Mg^'^ binding site—In an effort to elevate the concentration of free Mg^* in 
crystallization experiments (and thereby saturate the putative secondary binding site for 
Mg**), the magnesium acetate/acetate buffer used in previous crystallographic work (Poland 
et al., 1996) was replaced by Mg(N03)2 and an acetate-free buffer. Concentrations of 100 
and 300 mM Mg(N03)2 were employed, but in each case only the primary site for Mg*" was 
evident in electron density maps, when hadacidin was used as an analog of L-aspartate. The 
structure fi-om the acetate-free buffer in the presence of 100 mM Mg(N03)2 has been reported 
elsewhere (Hou & Honzako, unpublished data), and is identical to the complex from 300 mM 
Mg(N03)2. The Mg**-hadacidin complex [using 100 mM Mg(N03)2] serves here as a basis of 
comparison for the Ca**, Mn^* and Mg"*-L-aspartate complexes (Table 1). 
Ca** and Mn^" bind to the primary Mg^" site (Fig. 2). In contrast to the square 
pyramidal coordination of Mg^', however, Ca^" exhibits octahedral coordination and Mn^' 
exhibits octahedral coordination, but with symmetrically lengthened, apical coordinate bonds 
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(Table 2). (Mg^" in the Zn^*-Mg^* complex exhibits square pyramidal coordination as 
observed in the Mg**-hadacidin complex). Oxygen atoms from GDP, acetate, and hadacidin 
define the equatorial plane of the divalent cation, while backbone carbonyl 40 and the side 
chain of Asp 13 are the apical ligands. The distance of ODl of Asp 13 from Ca^*, Mn^* , and 
Mg** are 2.6, 2.7 zmd 2.9 A. respectively. In the Ca^* and Mn^* complexes, acetate occupies 
the y-phosphoryl site, whereas nitrate fills the corresponding site in the Mg^* complex. The 
average B values of acetate anion in the Mn^* and Ca^* complexes are higher than those of 
NOj" in the Mg^* complex. The bound acetate anion may be present in three orientations with 
its methyl group statistically occupying each of the three sites for oxygen atoms defined by 
the nitrate anion in the Mg^*-hadacidin complex. In acetate/magnesium acetate buffers, 6-
phosphoryl-IMP forms at the active site (Choe, Poland & Honzatko, unpublished data). In 
acetate/manganese acetate and in acetate/calcium acetate buffers, however, 6-phosphoryl-
IMP does not appear at the active site. 
Mg^'^-L-aspartate complex—The Mg""-hadacidin complex (Hou & Honzatko, 
unpublished data) and the Mg**-L-aspartate complex exhibit significant differences in the 
conformation of loop 299—304. Loop 299--304 of the Mg**-hadacidin complex is ordered, 
whereas the same structural element is disordered in the Mg^*-l-aspartate complex. The 
bound 1-apartate molecule is approximately at half-occupancy. Hence we have interpreted 
the conformational disorder in loop 299—304 as a mixture of two conformational states, only 
one of which is possible in the presence of bound aspartate. The two conformational states of 
loop 299—304 differ most significantly in the relative positions of residues 300—301 and the 
side chain of Arg303. In the presence of 1-aspartate, backbone amide 300 and the side chains 
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of Thr301 and Arg303 probably interact with the P-carboxylate of the amino acid substrate, 
whereas in its absence, the side chain of Arg303 probably falls outside of active site and 
residues 300-301 relax into space otherwise occupied by 1-aspartate (Fig. 3). Coordinate 
uncertainty in this region is high (approximately 0.6 a), largely because of the disorder in 
loop 299—304. 
Interactions involving the a-carboxylate and ct-amino groups of l-aspartate, however, 
are clear. The amino group of 1-aspartate makes nonbonded contact (approximately 4 a) with 
the base of IMP, and is positioned next to atom C6 of the purine base (Fig. 3). A neutral 
(doubly protonated) a-amino group (the most likely state at pH 7.7) can make weak 
hydrogen bonds with backbone carbonyl 38 and the side chain of Arg303. A positively 
charged a-amino group, however, cannot form a hydrogen bond with Arg303. Asp 13, 
Arg303 and Mg^" interact with the a-carboxyl group of l-aspartate. One of two oxygens of 
the a-carboxylate hydrogen bonds with the side chain of Arg305, whereas the second oxygen 
makes a close, nonbonded contact (2.88 a) with the side chain of Asp 13 and remains outside 
of the inner coordination sphere of the Mg** (3.72 a). The side chain of Asp 13 is now in the 
inner coordination sphere of the Mg"* (2.5 a), whereas in the Mg'^-hadacidinin complex, it 
remained outside of the inner coordination sphere. As discussed below, these differences in 
the interactions of 1-aspartate and hadacidin are significant in understanding the mechanism 
of catalysis. 
binding site—The highest electron density peak in the Zn^*-Mg^^ complex (at 
least double the density associated with Mg^* at its primary site) appears in the vicinity of 
His41. Refined thermal parameters, the absence of electron density attributable to Mg^" at 
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the corresponding site in Mg^"-hadacidin complexes, and the functional groups in contact 
with the site in question are all consistent with the coordination of Zn^*. One oxygen atom 
from the P-phosphoryl group of GDP, one from a bound phosphate molecule at the y-
phosphoryl site (see below) and NE2 of His41 are within 2.3 A of the Zn^^. The side chain of 
Glu221 is approximately 3 A from the Zn^*, and in relation to the other three ligating atoms 
defines a distorted tetrahedron (Fig. 4). Backbone carbonyl 222 at a distance of 4 A from the 
Zn'* is the only other atom near the zinc cation. 
The zinc cation fills the space occupied by the side chain of His41 in the Mg*^-
hadacidin complex, displacing the side-chain of His41 by approximately 1 A. In the Mg^"^-
hadacidin complex, NDl of His41 hydrogen bonds with the P-phosphoryl group of GDP, 
whereas in the Zn"*-Mg^* complex, NE2 of His41 coordinates to the Zn^"^, and NDl of His41 
hydrogen bonds directly with backbone carbonyl 53 and indirectly (through a bridging water 
molecule) with the side chain of Glu221. 
A second spherical peak of strong electron density appears at the y-phosphoryl site, 
and probably represents a bound phosphate molecule, introduced as an impurity associated 
with GDP. Acetate is present as a counterion to the Mg*", but unlike the Ca"* and Mn*" 
complexes, the presence of bound Zn** (and the concomitant increase in positive electrostatic 
charge) evidently favors the polyanion phosphate over the monanion acetate. The bound 
phosphate molecule hydrogen bonds with the side chain of Lysl6 and the backbone amide 
groups of Asp 13, His41 and Gln224, and coordinates to Zn"* and Mg^" (Fig. 4). The 
phosphate atom of the bound phosphate molecule is 3.3 A from 06 of IMP, its electron 
density and that of IMP being clearly separated (Fig. 5). The same ligands (GDP, phosphate. 
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hadacidin. IMP, and Mg^") in the absence of Zn^" form 6-phosphoryl-IMP at the active site 
(Choe, Poland & Honzatko, unpublished data). The distance between the phosphate atoms of 
bound phosphate and the P- phosphoryl group of GDP is 4.8 A. 
The tetrahedral nitrogen atom in hadacidin can undergo spontaneous chiral inversion. 
In all complexes involving hadacidin heretofore, the molecule has adopted a d-chiral center, 
whereas in the Zn^*-Mg^* complex hadacidin adopts the l-chirality (Fig. 6). The N-hydroxyl 
of hadacidin hydrogen bonds to the phosphate molecule and 06 of IMP (rather than to Asp 13 
as for the d-isomer). and is in contact with C6 of IMP (3.3A). The d-isomer and l-isomers of 
hadacidin exhibit identical coordination with Mg** through their N-formyl groups and 
identical interactions between the carboxylate group and residues 299 to 303. 
Discussion 
Striking parallels can be drawn now between the active sites of adenylosuccinate 
synthetase and GTP hydrolases. Adenylosuccinate synthetase has a glycine-rich, phosphate-
binding loop (P-loop) and a guanine-specific binding element, which are similar to the Gl­
and G4-region, respectively, of GTP hydrolases (Silva et ai, 1995; Sprang, 1997; Boume et 
ai, 1991). The synthetase and GTP hydrolases, however, apparently diverge in regard to 
Mg** recognition. The threonine/serine residue, which coordinates Mg** and follows the final 
GK-pair in the P-loop of p21 ras and G„ proteins, is replaced by Gly 17 in the E. coli 
synthetase. In addition, the consensus sequence for Mg** binding (G2 region) is absent from 
the synthetase. Nevertheless upon closer examination the side chain of His41 in 
adenylosuccinate synthetase structurally assumes the relative position of bound Mg^* in GTP 
hydrolases. 
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In addition to the G1 (P-loop) and G4 (guanine recognition) sequences, the synthetase 
also has a G3 sequence (central phosphate binding). In p21 ras, Asp57 of the G3 sequence 
(DXXGQ) interacts with Mg^* through an intervening water molecule, backbone amide 60 
hydrogen bonds with the y-phosphoryl group of GTP, and the side chain of Gln61 orients a 
water molecule for a nucleophilic attack on the y-phosphoryl group of GTP (Schlichting, et 
al., 1990). Similarly, Glu22I of the synthetase interacts with the protonated side chain of 
His41 (equivalent to Mg"* in p21 ras) through an intervening water molecule, backbone 
amide 224 hydrogen bonds with the y-phosphate of GTP, while its side chain interacts with 
6-oxygen of IMP, the attacking nucleophile in the phosphotransfer reaction (Wang et ai, 
1997). After the phosphotransfer step, the side chain of His 41 interacts with 6-phosphoryI 
IMP and directly hydrogen bonds with the side chain of Glu221. As a consequence, the 
intervening water molecule disappears. Similarly in p21 ras, Mg*" (analogous to His41) 
bonds directly to the side chain of Asp57 after GTP is hydrolyzed to GDP (Schlichting et al., 
1990). 
Despite the similarities noted above, the synthetase and GTP hydrolases diverge 
significantly in their capacities to catalyze the phosphotranfer reaction. In passing from the 
ground to the transition state in the nonenzymic hydrolysis of GTP by the preferred 
dissociative pathway, the P-y bridging oxygen atom undergoes a relatively large increase in 
negative charge; nonbridging oxygen atoms of the P-phosphoryl group have moderate 
increases in negative charge, and nonbridging oxygen atoms of the y-phosphoryl group have 
moderate decreases in negative charge (Admiraal et ai, 1995; Maeglev et al., 1996). His41 
of the synthetase putatively stabilizes the charge development on the nonbridging oxygen 
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atoms of the P-phosphoryl group, and the stabilizes charge development on the P-y 
bridging oxygen atom. In contrast, the Mg^* of GTP hydrolases coordinates nonbridging 
oxygen atoms of the y-phosphoryl group, which putatively destabilizes a dissociative 
transition state (Maegiev et al., 1996). In addition. Asp 13 and Gln224 of the synthetase 
putatively work in concert to stabilize the 6-oxyanion of IMP, consistent with catalysis by 
way of an associative pathway. In GTP hydrolases an amide corresponding to Gln224 is 
present (see above), but no catalytic base analogous to Asp 13 is present to abstract a proton 
from water and generate the hydroxyl anion. 
Ca^* or Mn'* occupying the primary Mg^* site of the synthetase and probably play the 
same role in catalysis as does Mg^*. The kcat values for the wild-type enzyme with Mg^*, 
Mn** and Ca** are 1.26, 0.930 and 0.235 sec"', respectively. The kcat values correlate well 
with distances between ODl of Asp 13 and the metal cation at the primary site (Table 2). The 
variation in distances is on the order of coordinate uncertainty, and hence the correlation 
between k^at distance of ODl to metal may be pure coincidence. Nonetheless, the 
metal to Asp 13 separation varies from 3.3 to 2.1 A in published crystal structures of the 
ligated synthetase, whereas other coordinate bonds to Mg*" vary over a range of less than 0.3 
A. At the very least the separation of Asp 13 from Mg"* is highly sensitive to small changes 
in ligation at the active site. On the basis of the proposed catalytic mechanism for the 
synthetase, which casts Asp 13 in the role of a catalytic base in the phosphotransfer reaction 
(Poland et ai, 1996), its coordination to the metal ion at the primary site should impair its 
function as a catalytic base. In addition, the Mn** and Ca^* complexes do not have 6-
phosphoryl-IMP at the active site, whereas the 6-phosphoryl intermediate is clearly present in 
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complexes (Choe, Poland & Honzatko, unpublished data). The absence of the 6-
phosphoryl intermediate implies that such an intermediate is less stable in an active site 
coordinated by Mn^^ or Ca^*. 
Zn^'may inhibit the synthetase by three possible mechanisms: (1) Zn^* coordinates 
His 41. a side chain essential for catalysis (Poland et ai, 1996, Kang et ai, 1997). (2) Zn^*, 
GDP, PO4'", Mg^*, and synthetase form a stable, dead-end complex. When the synthetase is 
complexed with Mg^"^, IMP, GDP and hadacidin, 6-phosphoryl-IMP appears in the active 
site. Evidently the addition of Zn^* defines a new fi-ee energy minimum which blocks the 
formation of 6-phosphoryl-IMP. (3) The strong interaction between Zn^* and a y-phosphoryl 
oxygen of GTP destabilizes a dissociative transition state. The presence of a stable Pi in the 
active site enlarges the active site and enhances the negative charges. Presumably, hadacidin 
binds the synthetase as the 1-isomer, allowing its N-hydroxyl group hydrogen bonds to the 
phosphate molecule. 
On the basis of kinetics, two Mg'* ions are required for full activity of the E. coli 
synthetase (Kang et al., 1995). The second Mg"* has low affinity for the active site 
approximately 114 ^M), and its binding to the synthetase is correlated with that of L-
aspartate. Efforts reported here have not provided a second Mg"* site. The second binding 
site for Mg**, however, may be sensitive to the state of ligation of the active site. The 
proposed mechanism for the synthetase assumes His41 serves as a catalytic acid in both the 
first and second partial reactions (Poland et al., 1997; Kang et ai, 1997). In order to fimction 
as a catalytic acid in the second partial reaction, the side chain of His41 must undergo a 
significant conformational change (Choe, Poland & Honzatko, unpublished data). 
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Conceivably, after the formation of 6-phosphoryl-IMP, bound l-aspartate could promote the 
binding of a second Mg^* to the 6-phosphoryI group of the intermediate instead of the 
conformational change in His41. Indeed, the direct interaction of His41 with the 6-
phosphoryl group of the intermediate (poland et al., 1997; Choe, Poland & Honzatko, 
unpublished data) has been observed only in dead-end, hadacidin complexes. Kinetics 
probes the transition state, which in this instance combines 6-phosphoryl-IMP and l-aspartate 
(not hadacidin). The" inability to find a secondary binding site for Mg** cannot be attributed 
to the difficulty of locating a relatively light metal ion in electron density maps. When 
manganese replaces magnesium, the synthetase still requires two cations for full activation 
(Kang et ai, 1995), but at 150 mM manganese acetate, a second cation site was not evident 
in the crystal structure. 
The Mg"*-l-aspartate complex reported here represents the interactions of the amino 
acid ligand prior to the formation of the 6-phosphoryl intermediate. In this complex l-
aspartate is in an incomplete state of association with the active site. The a-carboxylate of l-
asparate does not coordinate the Mg'* and has a close nonbonded contact with the side chain 
of Asp 13. In addition, the a-amino group of l-aspartate has a nonbonded contact with the 
purine base. Evidently, the amino acid substrate by itself carmot overcome the repulsive 
forces presented by the base of IMP and the side chain of Asp 13. On the basis of 6-
phosphoryl-IMP complexes (Choe, Poland & Honzatko, unpublished data), however, once 
the 6-phosphoryl intermediate forms, the side chain of Asp 13 relaxes into the inner 
coordination sphere of the Mg**, thus relieving one of the impediments to the complete 
association of l-aspartate with the active site. We suggest then, that l-aspartate binds in a 
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catalyticaly productive mode only after the formation of the 6-phosphoryl intermediate. Prior 
to the existence of 6-phosphoryi-IMP at the active site, l-aspartate associates loosely with the 
enzyme. Furthermore, a substantial portion of the binding energy in the coordination of l-
aspartate to Mg** may drive the compression of its a-amino group into atom C6 of IMP. The 
above interpretation is consistent with the results of isotope exchange kinetics (Cooper et al., 
1986; Bass et ai, 1984). which indicate that the phosphotransfer reaction can proceed in the 
absence of the amino acid substrate and that the synthetase favors the association of IMP and 
Mg^*-GTP prior to the addition of l-aspartate. 
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Table 1. Refinement Statistics for adenylosuccinate synthetase 
Mg" -L-Asp Ca" Mn'' Zn^'-Mg^' 
complex complex complex complex 
Resolution (A) 2.6 2.5 2.5 2.5 
Number of measurements 114,316 10,532 143,864 165,241 
Number of unique reflections 22,140 24,212 24,051 28,258 
Completeness of data set (%) 99 97 99 99 
Completeness of data in the last resolution shell (%) 98 (2.5-2.8 A) 96 (2.4-2.65 A) 98(2.40-2.65) 99 (2.36-2.60 A) 
8.2 7.8 10.3 7.8 
Number of reflections in refinement'' 15,969 14,014 16,008 15,428 
Number of atoms' 5,386 5,365 5,266 5,288 
Number of solvent sites 340 403 370 377 
/?-factor^ 0.18 0.16 0.18 0.18 
R-free' 0.27 0.24 0.27 0.28 
Refinement resolution (A) 6 to 2.6 6 to 2.5 6 to 2.5 6 to 2.5 
Mean B (A^) for protein 30 27 29 30 
rms deviations 
Bond lengths (A) 0.010 0.008 0.008 0.010 
Bond angles (deg.) 1.66 1.59 1.52 1.655 
Dihedral 24.6 24,1 24.3 24.06 
Improper dihedral angles (deg.) 1.41 1.30 1.32 1.39 
' R^y„ = Ij2||Iij - <Ij>|/E,E,l,,, where i runs over multiple observations of the same intensity, and 
j runs over all crystallographically unique intensities. 
All data in the resolution ranges indicated. 
" Includes hydrogens linked to polar atoms. 
" /^-factor = £ ||FJ - |F„,|| / S |FJ, > 0. 
' /?-free based upon 10% of the data randomly culled and not used in the refinement. 
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Table 2a. Selected contacts involving ligands of the Mn^^ and Ca^* complexes 
Mn2-»-
Ligand atom Contact atom Distance (A) Distance (A) 
IMP 
06 C Acetate 2.97 2.92 
N1 NE2 Gln224 3.01 2.72 
N7 ODl AspI3 2.97 3.21 
02' NE2 Gln224 3.02 2.82 
NH2 Arg303 2.78 2.50 
OlA O Val273 2.56 2.77 
02A NHI Argl43* 3.21 3.37 
OGl Thr239 2.87 2.52 
03A ND2 Asn38 2.80 3.14 
N Thrl29 2.59 2.57 
05' OGl Thrl29 2.63 2.50 
Hadacidin 
O Mg2+ 2.06 2.44 
OB OD2 Aspl3 3.19 2.52 
ODl Aspl3 3.22 2.77 
NH2 Arg305 2.97 2.62 
ODl NH2 Arg303 2.97 3.22 
OGl Thr301 2.77 2.92 
0D2 OGl Thr301 2.89 3.09 
N Thr301 2.89 3.11 
N Thr300 3.26 3.20 
Metal 
Mg2-^ 0D2 Acetate 2.26 2.44 
O Hadacidin 2.23 2.21 
02B GDP 2.15 2.07 
OlA GDP 2.11 2.07 
ODl Asp 13 2.60 2.73 
0 Gly40 2.56 2.60 
GDP 
NI ODl Asp333 2.80 2.77 
N2 0D2 Asp333 2.75 2.62 
06 OG Ser414 2.50 2.49 
N Gly4I4 2.94 2.59 
OlA Mg2+ 2.11 2.07 
02A N Thr42 3.26 2.92 
OIB N Glyl7 3.85 2.79 
NDI His4l 3.31 2.69 
028 Mg2- 2.12 2.07 
03B N Lys 16 2.64 2.63 
NZ Lysl6 2.51 2.50 
Acetate 
0D2 Mg2+ 2.26 2.44 
N Asp 13 3.28 3.00 
C3 N Gln224 3.05 3.03 
ODl N Gly40 3.28 3.00 
NZ Lysl6 2.90 2.85 
C 06 IMP 2.94 2.92 
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Table 2b. Selected contacts involving ligands of the Mg^'^-L-aspartate and 
Zn^*-Mg^* complexes 
Ligand 
atom 
Mg^'-L-Asp 
Contact atom Distance (A) Ligand atom 
Zn^'-Mg^* 
contact atom Distance (A) 
IMP IMP 
06 N3 Nitrate 2.95 06 P Pi 3.37 
N1 NE2 Gln224 3.17 Nl NE2 Gln224 2.73 
N7 ODI AspI3 2.88 N7 ODI A5pI3 2.82 
02' NE2 Gln224 3.39 02' NE2 Gln224 2.92 
NH2 Arg303 2.83 NH2 Arg303 2.78 
OlA o Val273 2.61 OlA O Val273 2.59 
02A NHl Argl43' 3.04 02A NHl Argl43» 3.10 
OGl Thr239 2.80 OGl Thr239 2.77 
03A ND2 Asn38 3.01 03A ND2 Asn38 3.09 
N Thrl29 2.66 N ThrI29 2.71 
OS- OGl Thrl29 2.86 05- OGl Thrl29 2.66 
L-Asp Hadacidin 
OAl Mg^* 3.85 O Mg'- 2.25 
OA2 NH2 Arg30S 2.88 OB ODI AspI3 3.03 
NE Arg305 3.05 G4 Pi 2.73 
GDI OGl Thr301 2.91 Nl IMP 2.96 
OD2 N Thr301 3.27 GDI NH2 Arg303 3.03 
N Thr300 3.39 OGl Thr30I 3.10 
N NHl Arg303 3.05 OD2 OGl Thr30I 2.92 
Nl IMP 4.37 N Thr30I 2.98 
O Asn38 4.20 N Thr300 3.05 
Metal Metal 
Mr* 02 Nitrate 2.32 Mg2' 04 Pi 2.20 
OAl L-Asp 3.85 O Hadacidin 2.23 
02B GDP 2.26 G2B GDP 2.13 
OIA GDP 2.24 OlA GDP 2.12 
ODI Aspl3 2.63 GDI Aspl3 2.95 
O Gly40 2.33 G Gly40 2.20 
GDP GDP 
Nl ODI Asp333 3.07 Nl ODI Asp333 2.88 
N2 0D2 Asp333 2.61 N2 0D2 Asp333 2.72 
06 OG Ser4I4 2.52 06 OG Ser414 2.51 
N GIy414 3.32 N GIy414 3.13 
OlA Mg^' 2.24 OlA Mg^* 2.12 
02A N Thr42 3.14 G2A N Thr42 2.95 
GIB N Glyl7 3.03 GIB N Glyl7 3.10 
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Figure 1. Overview of the Zn^* complex of the synthetase. Stereo view, drawn with 
MOLSCRIPT, of a single monomer of the synthetase dimer showing IMP, 
Mg**, P04^', Zn^*, and GDP as ball-and-stick models. 
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Figure 2. Stereoview of interactions between and the active site. Ligands [GDP, 
Acetate, and Hadacidin are shown] are drawn with lines. Donor-acceptor interactions 
are presented with dashed lines. 
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Figure 3. Stcreoview of interactions bet^veen L-aspartate and the active site. Ligands [L-
aspartate, nitrate, IMP, and Mg^' are shown] are drawn with bold lines. The thin lines 
represent the alternative conformation of loop 299-303. Donor-acceptor interactions 
are presented with dashed lines. 
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Figure 4. Stereoview of interactions between ligands (Pi, Zn'^, and Mg'^) and the active site. 
Ligands [hadacidin (Had), PO^'", IMP, Zn^', and Mg^'] are drawn with bold lines. 
Donor-acceptor interactions are presented with dashed lines. 
IMP IMP 
Figure 5. Stercoview of electron density associated with ligands in the complex. The 
electron density, contoured at 2.5 ct using a cut off radius of 0.9 A, conies from a 
ligand-excised omit map. Zvi'* and other active site ligands are represented with black 
spot, and bold lines. The complex is crystallized from a solution containing Zn^\ 
Mg'',hadacidin, GDP, IMP. 
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Figure 6. Stereoview of interactions between Hadacidin and the active site. Ligands [only 
hadacidin (Had), PO/', IMP, and are shown] are drawn with bold lines. Donor-
acceptor interactions are presented with dashed lines. 
38 
CHAPTER 3. IMP ALONE ORGANIZE THE ACTIVE SITE OF 
ADENYLOSUCCINATE SYNTHETASE FROM Escherichia coli 
A paper to be submitted to Biochemistry 
Zhenglin Hou, Wenyan Wang, Herbert J. Fromm, and Richard B. Honzatko 
Abstract 
A complete set of substrates/substrate analogs of adenylosuccinate synthetase from 
Escherichia coli induces dimer formation and a transition from a disordered to an ordered 
active site. The most striking of the ligand-induced effects is the movement of loop 40-53 by 
up to 9 A. Crystal structures of the partially ligated synthetase, which combine either IMP 
and hadacidin or IMP, hadacidin and Mg^*-pyrophosphate, have ordered active sites, 
comparable to the fully ligated enzyme. More significantly, a crystal structure of the 
synthetase with IMP alone exhibits a largely ordered active site, which includes the 9 A 
movement of loop 40-53, but does not include conformational adjustments to backbone 
carbonyl 40 (Mg"* interaction element) and loop 299-304 (hadacidin/l-aspartate binding 
element). The principal interactions of the IMP-synthetase complex involve the 5'-
phosphoryl group of the ligand. Evidently, IMP by itself can drive most of the 
conformational changes, some of which include the formation of salt links some 30 A away 
from its 5'-phosphoryl group. The above provides a structural basis for the binding 
synergism of ligands, the significant effect of mutations on kcat for specific residues far from 
the site of catalysis, and the complete loss of substrate efficacy due to minor alterations of the 
5'-phosphoryl group of IMP. 
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Introduction 
Adenylosuccinate synthetase (IMP:l-aspartate ligase (GDP forming) E.C. 6.3.4.4) is 
essential to most organisms (1), catalyzing the first committed step in de novo biosyntheses 
of AMP: 
Mr* 
IMP + L-aspartate + GTP < • adenylosuccinate + GDP + Pi 
The kinetic mechanism is random sequential (2) with a preference for the binding of l-
aspartate to the preformed E-IMP-GTP complex (3,4). The enzyme facilitates the formation 
of 6-phosphoryl-IMP by nucleophilic attack of the 6-oxo group of IMP on y-phosphory 1 
group of GTP (5-7). The amino group of l-aspartate then displaces the 6-phosphoryI group 
to form adenylosuccinate. 
According to the "induced fit" concept (8) some fraction of the enzyme-substrate 
binding energy stabilizes the transition state. Structures of the unligated and ligated forms of 
the synthetase differ in that several disordered loops of the unligated enzyme, which 
contribute residues essential to catalysis, form ordered structures in the presence of substrates 
and substrate analogs (9-12). The largest conformational change (approximately 9 A) occurs 
in the loop 42-53, which folds against the guanine nucleotide, putatively stabilizing the 
transition state by its interactions with Mg** and the phosphoryl groups of the guanine 
nucleotide (10). 
The largest conformational changes and the vast majority of ligand-protein hydrogen 
bonds are at the guanine nucleotide pocket, and hence implicate GTP in the structural 
rearrangements. Data equally compelling, however, suggest an IMP-driven conformational 
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change. IMP is cracial for the dimerization of the synthetase monomers (13). The 5'-
phosphoryl group of IMP is essential for catalytic activity of the synthetase; IMP analogs, in 
which one phosphate oxygen of IMP is replaced by a carbon, nitrogen or sulfur atom, are 
poor substrates (14). The 5'-phosphate of IMP interacts with the side chain of Asn38, and 
the mutation of Asn38 to alanine lowers kcat 200-fold, but has no effect on for all three 
substrates (15). Evidently, the total binding energy of the Asn38-IMP hydrogen bond goes 
toward the stabilization of the transition state. 
Presented here are crystal structures of adenylosuccinate synthetase from Escherichia 
coli, which provide direct evidence of the central role played by IMP in organizing the active 
site. One complex (hereafter the pyrophosphate complex) has IMP, hadacidin (an analog of 
l-aspartate) and Mg^*-pyrophosphate (in place of Mg^^-GDP) at an ordered active site, hence 
demonstrating that the guanine base is not essential for reorganization of the active site. A 
second complex has IMP and hadacidin (hereafter the IMP-hadacidin complex) at an ordered 
active site that does not bind Mg**, even at concentrations as high as 100 mM. The 
association of Mg^" with the active site then, requires the phosphoryl moiety of the guanine 
nucleotide. A third complex has IMP alone (hereafter the IMP complex) and, aside from the 
l-aspartate binding loop, has an ordered active site. Evidently, IMP-enzyme interactions 
alone suffice in driving the major conformational transitions of the synthetase active site. 
The above series of structures provide a mechanistic basis for ligand binding synergism, for 
the substantial effects on catalytic rates due to mutations well removed from the active site, 
and for the requirement of an unmodified 5'-phosphoryl group of IMP. 
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Experimental procedures 
Purification of enzyme from E. coli—The synthetase was prepared as described 
previously (16) from a genetically engineered strain of E. coli. Enzyme purity exceeded 95% 
as determined by SDS-PAGE. 
Crystallization—Hadacidin was a generous gift of Drs. Fred Rudolph and Bruce 
Cooper, Department of Biochemistry and Cell Biology, Rice University. All other reagents 
came from Sigma. Crystals were grown by the method of hanging drops under conditions 
similar to those reported previoulsy (10). In growing crystals of the pyrophosphate complex, 
droplets contained equal volumes (6 |iL) of an enzyme solution [HEPES (30 mM), 
pyrophosphate (2 mM), IMP (4 mM), hadacidin (4 mM), and protein (18 mg/ml) at pH 6.8] 
and a crystallization buffer [polyethylene glycol 8000 (16% w/v), cacodylic acid/sodiimi 
cacodylate (pH 6.5, 100 mM), magnesium acetate (100 mM)]. Mg^* of the crystallization 
buffer precipitated pyrophosphate at 2 mM. The precipitate was removed by filtration (0.2 
^m pore) before crystallization. Hence, the actual concentration of pyrophosphate is 
significantly lower than 2 mM, but saturating under the conditions employed. The final pH 
of the crystallization buffer was 6.5. Wells contained 500 fiL of crystallization buffer. 
Conditions of crystal growth for the IMP-hadacidin complex and the IMP complex differ 
from those of the pyrophosphate complex only in the omission of either pyrophosphate or 
both pyrophosphate and hadacidin. Crystals of approximately 0.5 mm in all dimensions and 
belonging to the space group P3221 grew in about 1 week under all sets of conditions. The 
crystals are isomorphous to those of Poland et al. (1996). 
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Data collection and reduction—Data were collected on a Siemens area detector at 
100 K and were reduced by using XENGEN (17). The data sets were at least 98% complete 
to their nominal resolution (where <I/ct(I)> = 2; Table 1). One crystal from each complex 
was used for data acquisition. 
Model refinement—Starting phases were calculated from the fully ligated complex 
(10), omitting all ligands and solvent molecules. Ligand models were fit to the resulting 
electron density map, followed by a cycle of refinement using XPLOR (18). Constants of 
force and geometry for the protein came from Engh and Huber (19), and those for hadacidin 
from Poland et al. (10). Constants of force and geometry for pyrophosphate were based on 
the phosphoryl groups of OTP and ATP. In early rounds of refinement, all the crystal 
structures were heated to 2000 K and then cooled in steps of 25-300 K. In later rounds of 
refinement, the systems were heated to 1000 -1500 K but cooled in steps of 10 K. After the 
slow cooling protocol was complete (at 300 K), the models were subject to 120 steps of 
conjugate gradient minimization, followed by 20 steps of individual B-parameter refinement. 
Individual B-parameters were subject to the following restraints: nearest neighbor, main 
chain atoms, 1.5 A*; next-to-nearest neighbor, side chain atoms, 2.0 A*; nearest neighbor, 
side chain atoms, 2.0 A^ and next-to-nearest neighbor, side chain atoms, 2.5 A*. 
All data sets from P3221 crystals of adenylosuccinate synthetase exhibit significant 
anisotropy whenever a ligand is not bound to the l-aspartate/hadacidin pocket. Hence for the 
IMP-compIex alone, an overall anisotropic scale factor was employed in the scaling of F^aic to 
Fobs, which brought about reductions in the R-factor and (Table 1) of approximately 0.02. 
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Water molecules were added if (i) electron density at a level 2.5a was present in maps 
based on Fourier coefficients (IF065I - \Fcalc\)^^O^calc) (") acceptable hydrogen 
bonds could be made to an existing atom of the model. Sites for water molecules were 
omitted if after refinement they fell beyond 3.3 A from the nearest neighbor. In addition, 
water molecules were deleted from the model if their thermal parameters exceeded 80 A^. 
Harmonic restraints (50 kcal/mol) were placed on the positions of the oxygen atoms of water 
molecules to allow new water molecules to relax by adjustments in orientation. Occupancies 
of water molecules were not refined because of the high correlation between occupancy and 
thermal parameters. Thus solvent sites with B values between 50 and 80 A^ probably 
represent water molecules with occupancy parameters below 1.0 and thermal parameters 
substantially lower than those reported from refinement. 
Results 
Quality of the refined models—The models reported here will be deposited with the 
Protein Data Bank, Brookhaven National Laboratory. The method of Luzzati (20) indicates 
an uncertainty in coordinates of 0.3 A for the structxu-es. The amino acid sequence used in 
refinement is identical to that reported previously (12). Results of data collection and 
refinement are in Table 1. The program PROCHECK (21) indicates better stereochemistry 
than is typical for a structure of 2.5 A resolution. All residues fall within the generously 
allowed region of the Ramachandran plot except Gin 10 as noted in previous studies (9,12). 
Superposition of the present structures onto the nitrate complex (10) give root-mean-square 
deviations in Ca coordinates of approximately 0.3 A, except for the IMP complex, for which 
the deviation is larger (0.36 A). Thermal parameters vary from 10—60, 10-75 and 10—80 A^ 
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for the pyrophosphate, IMP-hadacidin, and IMP complexes, respectively. An overview of the 
pyrophosphate complex is presented in Figure 1. 
IMP, hadacidin, -pyrophosphate complex—A difference map of the 
pyrophosphate complex using calculated phases based on the coordinates of the nitrate 
complex (Mg^*. GDP, and nitrate molecules omitted) clearly displays three isolated, ball-like 
densities at the active site. One spheroid of electron density is at the observed Mg*" site, 
whereas the other two are at the putative P- and y-phosphoryl sites of GTP. The thermal 
parameters for atoms of pyrophosphate and Mg^* placed in this density are comparable to 
each other, but higher than those of nearby atoms of the protein. Given that Mg^* and 
pyrophosphate are depleted by precipitation (see Experimental), the above may simply reflect 
a bound Mg^*-pyrophosphate complex at less than full occupancy. An occupancy of 0.70 for 
Mg'* and pyrophosphate reduces their thermal parameters to values consistent with the 
surrounding protein. The absence of electron density for the bridging oxygen of 
pyrophosphate may reflect greater thermal motion for this atom. No negative difference 
density is associated with the bridging oxygen, and the observed distance (3 A) between the 
centroids of the two balls of electron density assigned to pyrophosphate is too short for the 
simultaneous binding of two molecules of inorganic phosphate. 
The interactions of hadacidin and IMP with the synthetase in the pyrophosphate 
complex are essentially identical to those of hadacidin and IMP in the nitrate complex (10). 
Hence, presented here are only interactions of the pyrophosphate molecule and Mg^*. The 
two phosphoryl groups of pyrophosphate (hereafter called the P* and y- phosphoryl groups of 
pyrophosphate) bind to the putative P- and y-phosphoryl sites of GTP (Fig. 2). The (5-
phosphoryl group hydrogen bonds with backbone amides 15, 16 and 17, and coordinates to 
Mg^" (Table 2; Fig. 2). The y-phosphoryl group coordinates to Mg^* as well, and also 
hydrogen bonds with Lysl6, His41 and backbone amides 13,40 and 224. Mg** coordinates 
with two. nonbridging oxygen atoms of pyrophosphate (one each from the P- and y-
phosphoryl groups), backbone carbonyl 40, and the A^-formyl group of hadacidin (Table 2). 
The side-chain of Asp 13 (2.9 A away from Mg^") is not part of the inner coordination sphere 
of the Mg^*. Hence, the Mg^* in the pyrophosphate complex is four-coordinated. Mg^* in the 
nitrate complex (10) is five-coordinated; the a-phosphoryl group of GDP in the nitrate 
complex, which has no analogous element in the pyrophosphate complex, provides the 
additional coordinate bond. 
Loop 42—53 of the pyrophosphate complex adopts the closed conformation observed 
in previous studies (5,10,11). The backbone atoms of residues 38—41 move about 1 A toward 
the 5'-phosphoryl group of IMP. This small movement is amplified into the 9 A 
displacement of the Ca atom of residue 46. The conformational change of loop 42—53 
ruptures the salt linkage between His41 and the side chain of Asp21, observed in the 
unligated structure. In the pyrophosphate complex NDl of His41 hydrogen bonds with the 
side-chain Glu221, while NE2 of His42 interacts with the y-phosphoryl group of 
pyrophosphate. The peptide linkage between residues 39 and 40 reorients, allowing the 
backbone carbonyl of Gly40 to coordinate the Mg"'. 
The large conformational change in loop 42—53 of the pyrophosphate complex, 
described above, is accompanied by additional conformational changes which are consistent 
with those of the nitrate complex (10). The peptide linkage between residues 223 and 224 
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reorients, allowing backbone amide 224 to hydrogen bond with the pyrophosphate molecule. 
The C-terminal end of helix H2 shifts by as much as 3 A toward loop 42—53, allowing the 
side chain of Arg89 to hydrogen bond with the side chains of Glu48 and ThrSO and the side 
chmn of Glu82 to hydrogen bond with backbone amides 53 and 54 (Fig. 3). Asp333, Lys331 
and Ser414 (residues that interact with the base of guanine nucleotide), and loop 416—421 
move as much as 2.5 A toward loop 42—53. The conformational change in loop 416—421 
allows Asp418 to hydrogen bond with backbone amides 46 and 48, the backbone amide 419 
hydrogen bond with backbone carbonyl 44, the side chain of Arg419 to hydrogen bond with 
the side chain of Asp21, and backbone carbonyl 417 to hydrogen bond with backbone 
carbonyl 42 through a bridging water molecule. A water molecule occupies the same site in 
fully ligated complexes (5,10,11), hydrogen bonding to the 2'-0H of GDP in addition to the 
above named backbone carbonyl groups. Loop 299—303 becomes ordered; OGl of Thr300 
hydrogen bonds with backbone carbonyls 38 and 39 and to the side chain of His53. Hence 
even in the absence of the ribosyl and base moieties of the guanine nucleotide, the 
conformation of the guanine nucleotide pocket in the pyrophosphate complex is identical to 
that observed in fully ligated complexes, where Mg**-GDP is bound. 
IMP-hadacidin complex— IMP and hadacidin interact the with the synthetase as 
observed in the pyrophosphate complex above. No electron density, however, is evident for 
Mg"*, even though the concentration of Mg^" in the crystallization solution is approximately 
100 mM. Nonetheless, the loss of the coordinate bond between Mg"^ and the N-formyl group 
of hadacidin does not perturb other interactions between hadacidin and the synthetase. 
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The conformational differences between the pyrophosphate complex (above) and the 
IMP-hadacidin complex are in the immediate vicinity of the binding site for pyrophosphate-
Mg^* (Fig. 4). In the IMP-hadacidin complex, the side chain of His41 interacts with GIu221 
alone. Both side- and main-chain atoms in the vicinity of the residues 39—40 possess 
relatively high thermal parameters in the IMP-hadacidin complex. Backbone carbonyl 40, 
which coordinates to Mg^" in the pyrophosphate complex, interacts with OGl of Thr 42 in 
the IMP-hadacidin complex after a -90° rotation of the peptide plane between residues 41— 
42. Lysl6, which hydrogen bonds with pyrophosphate, interacts exclusively with the side 
chain of Glul4 in the IMP-hadacidin complex. The absence of the entire guanine nucleotide 
then causes localized conformational change in the vicinity of the Mg^*, P-phosphoryl and y-
phosphoryl sites. 
IMP complex—The conformation of the active site of the IMP complex is similar to 
those of the pyrophosphate and IMP-hadacidin complex in regard to the movement of loop 
42—53. In addition, the high thermal parameters and hydrogen bonding (Thr42 to backbone 
carbonyl 40) within the Mg** recognition element (residues 39—40), observed in the IMP-
hadacidin complex, are preserved in the IMP complex. Significant differences in 
conformation, however, are evident. The base of IMP, stacked against hadacidin in the other 
complexes, moves 0.8 a into the hadacidin/l-aspartate pocket. 06 of IMP hydrogen bonds to 
NZ of Lysl6 and backbone amide 224 by way of a bridging water molecule which lies in the 
putative y-phosphoryl pocket of OTP (Fig. 5). Asp 13 still interacts with IMP, but in order to 
maintain the ODI to NI hydrogen bond, its side chain must rotated by approximately 90° 
about X'- In contrast, the base of IMP and the carboxylate of Asp 13 are coplanar in 
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complexes which have either hadacidin or both hadacidin and Mg^* at the active site (5,10). 
The hadacidin/l-asparate binding element (residues 299—305) is disordered in the IMP 
complex. Density is present for Arg305 and Arg303, but thermal parameters for these 
residues are high, suggesting disorder. The side chain of Axg305, which hydrogen bonds to 
hadacidin and to the a-phosphoryl group of GDP in fully ligated complexes (5,10), has a 
different conformation in the IMP complex which approximates that of the unligated enzyme 
(9.12). Arg303, which interacts with the carboxylate of hadacidin, 02' of IMP, OGl of 
Thr300, and backbone carbonyl 127 in the IMP-hadacidin and pyrophosphate complexes, 
hydrogen bonds weakly with 02' of IMP and backbone carbonyl 128. 
Discussion 
The structures presented here along with previously reported complexes of the 
synthetase permit a detailed analysis of the conformational changes induced by a particular 
ligand and the significance of these conformational changes to ligand binding synergism and 
stabilization of the transition state. The following discussion focuses on conformational 
transitions which are presented schematically in Fig. 6. 
IMP alone induces long-range conformational changes in the active site of 
adenylosuccinate synthetase (Fig. 6a,b). Loops 42—53, 416—421 and 120—130 attain 
conformations in the presence of IMP which are similar to those observed in complete ligand 
complexes of the synthetase. IMP-induced conformational changes in loops 42—53 and 416-
-421 create the binding pocket for Mg""-GTP, and hence provide a structural basis for the 
binding synergism between ligands at the IMP and GTP sites. Asn38, located just before the 
beginning of loop 42—53, hydrogen bonds with the 5'-phosphoryl group of IMP. The energy 
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of that hydrogen bond, in its entirety, must stabilize the transition state as the mutation of 
Asn38 to alanine reduces kcat up to 200-fold without an effect on the Km of substrates (15). 
Arg419 and Asp21 form a salt-link some 30 A away from the 5'-phosphoryl group of IMP, 
which evidently stabilizes the IMP-induced conformation of the synthetase. Mutations at 
positions 21 and 419 lower catalytic rates by 10 to 20-fold (15). The 5'-phosphoryI group of 
IMP enhances formation of synthetase dimers from monomers by directly interacting with 
Argl43 from the subunit related by molecular symmetry (12,13). Loss of substrate efficacy 
due to single atom replacements of nonbridging oxygens of the 5'-phosphoryl group of IMP, 
further emphasizes a strict requirement for an unmodified phosphoryl group (14). The 5'-
phosphoryl group of IMP then, is not simply a handle by which the synthetase can grasp one 
of its substrates, but a functional group of importance equal to that of any catalytically 
essential residue. 
Mg**-GTP could perhaps elicit conformational movements in loop 42-53 and loop 
416-421 comparable to those induced by IMP. Fluorescence studies, however, suggest 
otherwise (22). Tb^*-GTP binds to the synthetase with affinity comparable to the of 
GTP. Changes in fluorescence probably reflect differences in the environments of Tb^*-GTP 
free in solution as opposed to its enzyme-bound state. The addition of IMP, however, results 
in further change in terbium fluorescence. As the terbium cation is a potent inhibitor of the 
synthetase, phosphoryl transfer from GTP to IMP is unlikely. Instead, the change in terbium 
fluorescence in response to IMP may be a consequence of conformational change in loop 42-
-53. Soaking Mg^^-GDP into preformed crystals of the unligated enzyme revealed the 
anticipated interactions between the base of GDP and the active site, but the pyrophosphoryl 
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group did not interact strongly with the enzyme, and a site for bound Mg^* was not evident 
(23). The result of the soaking experiment is consistent with the inability of the guanine 
nucleotide alone to trigger a conformational change in loop 42—53, but as crystal packing can 
restrict conformational responses to ligand binding, the complex obtained by soaking does 
not constitute irrefutable proof of this issue. 
The Mg^*-polyphosphoryl moiety of the guanine nucleotide evidently fine tunes the 
IMP-induced conformational change by enforcing modest change in the backbone of residues 
40-42, and the side chains of Asp 13, Lysl6, and His41 (Fig 6c,d). [Asp 13 and His41 are 
essential catalytic side chains (24)]. In fact, most of the binding energy of the Mg^*-
polyphosphate moiety of the guanine nucleotide probably stabilizes the transition state, rather 
than promoting substrate affinity. GTP, GDP, and GMP have comparable binding affinities 
for the synthetase (1). In addition, mutations of GlyI2 to valine, Glul4 to alanine, GlyI5 to 
valine and Glyl7 to valine individually reduce kcat-> but do not affect the of GTP (24,25). 
These residues belong to the P-loop of the synthetase, and in combination with residues 40-
42 define the polyphosphoryl binding site. Asp 13 and Lysl6 have decidedly different 
conformations and/or interactions in the IMP complex relative to other complexes with more 
complete ligation of the active site. Although IMP binds and induces significant 
conformational change in loop 42—53, the ligand itself and much of the catalytic machinery 
(Asp 13, His41, backbone carbonyl 40, Lysl6) are not in their proper places until Mg^"-
pyrophosphate (or Mg^'-GDP) binds to the active site (Fig 6). 
The absence of boimd Mg^" in the hadacidin-IMP complex, even though Mg^" is 
present at a concentration of 100 mM, clearly demonstrates the absolute requirement for the 
guanine nucleotide in the association of Mg^* with the active site. Yet in the absence of 
bound cation, hadacidin still interacts with the protein as it does in fully ligated complexes of 
the synthetase (Fig. 6). The binding of hadacidin to the enzyme-IMP complex evidently 
brings about several small, but important conformational changes (Fig. 6). In the presence of 
hadacidin, IMP now adopts the set of interactions observed in fully ligated complexes. The 
base of IMP and the carboxylate of Asp 13 are coplanar. Hadacidin places Arg305 in a 
conformation which favors an interaction with the a-phosphoryl group of guanine 
nucleotides. Loop 299-304 is ordered, with Arg303 participating in the set of interactions of 
fully ligated complexes. The side chain of Thr300 of that loop, in turn, hydrogen bonds with 
backbone carbonyls 38 and 53, further stabilizing the conformation of loop 42-53 and the 
Mg** binding element. Hence hadacidin (and presumably l-asparate) induces conformational 
change in the active site, which promotes productive binding of IMP and GTP. 
Adenylosuccinate synthetase is just one of a growing list of enzymes which employ 
flexible loops in biochemical function (26-30). The precise ftmctional role of flexible loops 
can vary significantly. AMP, as an allosteric inhibitor, putatively modulates the 
conformational state of a dynamic loop in fnictose-l,6-bisphosphatase (26). A dynamic loop 
in S-adenosylmethionine synthetase may act as a gate, blocking access to the active site and 
modulating substrate affinity (27). The role of a dynamic loop in lactate dehydrogenase (28), 
however, is analogous to that of adenylosuccinate synthetase. Pyruvate induces a 
conformational change in a loop of lactate dehydrogenase, allowing the side chain of Lysl09 
to interact with the carbonyl oxygen of the substrate. Directed mutation of Lysl09 reduces 
activity 1500-fold with little effect on substrate affinity (31). In the case of adenylosuccinate 
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synthetase, the large conformational change in loop 42—53 is an amplification of a small 
conformational change involving the interaction of Asn38 with the 5'-phosphoryl group of 
IMP. Asn38, then, is a sensor. When IMP binds, the enzyme probably dimerizes and the 
active site goes into a state of readiness. Mg^^-GTP and l-aspartate, acting alone, probably 
do not have the same effect on the global conformation of the synthetase or its state of 
oligomerization. As conforaiational transitions in the synthetase span over a distance of 30 
A, the signal transmission from the sensor is on a scale comparable to that of allosteric 
enzymes. In a sense, the 5'-phosphoryI pocket is a regulatory/activation site contained with 
the active site of the synthetase. 
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Tabic 1. Refinement Statistics for adenylosuccinate synthetase 
PPi IMP-Had IMP 
complex complex complex 
Resolution (A) 2.6 2.6 2.8 
Number of measurements 85,975 121,026 99,750 
Number of unique reflections 22,089 22,708 20,293 
Completeness of data set (%) 99 91 98 
Completeness of data in the last resolution shell (%) 99 (2.55-2.75 A) 90 (2.6-2.9 A) 96 (2.6-2.8 A) 
n a 
"lym 8.34 12.2 11 
Number of reflections in refinement'" 14,560 13.332 13,495 
Number of atoms' 5,028 5,026 5,039 
Number of solvent sites 350 302 312 
y?-factor^ 0.19 0.18 0.196 
/?-free' 0.27 0.29 0.283 
Refinement resolution (A) 5 - 2 . 6  5 - 2 . 6  5 - 2 . 7  
Mean B (A*) for protein 31 32 30 
rms deviations 
Bond lengths (A) 0.011 0.013 0.010 
Bond angles (deg.) 1.77 1.82 1.710 
Dihedral 24.3 24.3 24.6 
Improper dihedral angles (deg.) 1.58 1.65 1.53 
' /?,y„ = £jS||l|j - where / runs over multiple observations of the same intensity, and 
j runs over all crystallographically unique intensities. 
** All data in the resolution ranges indicated. 
' Includes hydrogens linked to polar atoms. 
" /?-factor = Z ||F^.| - / 2 |F^.| > 0. 
' /?-free based upon 10% of the data randomly culled and not used in the refinement. 
56 
Table 2. Selected contacts involving ligands of the PPi, IMP-Had and IMP complexes 
PPi IMP-Had IMP 
Ligand atom Contact atom Distance (A) Distance (A) Distance (A) 
IMP 
06 NE2 GIn224 2.76 3.08 2.86 
N1 ODl Aspl3 2.87 2.85 2.96 
N7 NE2 Gln224 3.29 3.21 2.72 
02' NH2 Arg303 2.77 2.92 3.23 
O Val273 2.68 2.50 2.86 
OlA NHl Argl43* 2.98 3.30 3.19 
02A OGl Thr239 2.92 3.20 2.59 
ND2 Asn38 2.78 2.91 3.29 
03A N Thrl29 2.64 2.92 3.09 
OGl Thrl29 2.62 2.80 2.71 
05' OGl ThrI28 4.75 4.65 3.24 
Hadacidin 
O Mg2+ 2.33 — 
OB OD2 AspI3 2.70 3.10 
ODl Aspl3 2.77 2.80 
NH2 Arg305 2.90 2.78 
ODl NH2 Arg303 2.83 2.78 
OGl Thr301 2.89 2.82 
OD2 OGl Thr301 2.87 2.92 
N Thr301 2.82 2.88 
N Thr300 3.02 2.88 
Metal 
Mg2* OlD PPi 2.33 
02B PPi 2.34 
ODl Asp 13 2.88 
O Gly40 2.12 
O 2.33 
PPi 
02D N Gln224 2.74 
NE2 Hls41 3.01 
OlD Mg2+ 2.37 
N Gly40 3.32 
03D NZ LysI6 2.64 
N Asp 13 2.70 
Py 06 IMP 3.45 
04B NE2 His41 3.06 
Mg2+ 2.34 
03B N Giyl5 3.08 
NZ Lysl6 2.40 
02B N LysI6 2.92 
N Glul4 3.22 
OIB N Glyl7 2.97 
N LysI6 2.80 
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Figure 1. Overview of the pyrophosphate complex of the synthetase. Stereoview, 
drawn with MOLSCRIPT, of a single monomer of the synthetase dimer 
showing IMP, Mg"* and PPi as ball-and-stick models. 
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Had 
,Gln224 \ 
Gly40 
Asp13 
His41 Glu1 
Gly17 
Gly15 
Lys16 
IMP 
Had 
Gln224. 
. Gly40 
Asp13"0 
His41 Glu1 
Gly17 
Gly15 
Lys16 
Figure 2. Stereoview of interactions between PPi and the active site. Ligands [only 
hadacidin (Had), PPi, and are shown] are drawn with bold lines. Donor-acceptor 
interactions (corresponding distances listed in Table 2) are presented with dashed lines. 
IMP IMP 
\ Asn38 \ Asn38 
Asp 13 Asp 13 
Thr4; Thr4; 
'Wat Wat 
Asp21 Asp21 
Pro417 J Pro417 
Val44 Val44 
Arg41. Arg4 
open-loop open-loop 
Gly47 Gly47 
Asp418 Asp41B 
Asn46 Asn46 
Figure 3. Stereoview of the interloop interactions between loop-40 and loop-400. The ioop-
40 is shown as bold lines, the thick lines represent the trace of CA between the residue 
16-26. Donor-acceptor interactions are presented with dashed lines. 
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Thr4: GDP 
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Hls41 • 
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- -+, Qly40" 
-T 
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Thr42^ GDP 
Figure 4. Stereoview of conformational change in residues 40 and 41 between IMP-Had 
and nitrate complexes. The IMP-had complex is shown as bold lines. 
Thr128 Thr128 Arg143' Arg143' 
Thr239 
\ AsnSB \ Asn38 
Arg303 
IMP 
Gln224 Qln224 
Asp13 y Wal506 Asp13 Watsoe 
Lysie Lysie 
Figure 5. Stereoview of interactions between IMP and the active site. Ligand, IMP, is drawn 
with bold lines. Donor-acceptor interactions (corresponding distances listed in Table 
2) are presented with dashed lines. 
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Figure 6. A sketch of the conformational changes of the synthetase active site in 
response to various ligands. 
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b:Active site in IMP-coogplex 
lOOp^lSO 
leep-300 leop*300 
e:Active fits in ZHP-Had ca^lAX 
PPiMsr* 
m 
loop->400 
d: Active (it* in PPi-lig'* coqplax 
Had 
2* 
e:Active site in IMP-Had-FPi-Mg complex 
Figure 6. (continued from the last page) A sketch of the conformational changes of 
the synthetase active site in response to various ligands. 
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CHAPTER 4. EFFECTORS OF THE STRINGENT RESPONSE TARGET THE 
ACTIVE SITE OF Escherichia coli ADENYLOSUCCINATE SYNTHETASE 
A paper to be submitted to the Journal of Biological Chemistry 
Zhenglin Hou, Michael Cashel, Herbert J. Fromm and Richard B. Honzatko 
Abstract 
Guanosine 5'-diphosphate 3'-diphosphate (ppGpp), a pleiotropic effector of the 
stringent response, potently inhibits adenylosuccinate synthetase from Escherichia coli as an 
allosteric effector and/or as a competitive inhibitor with respect to OTP. Crystals grown of 
the synthetase in the presence of IMP, hadacidin, NO," and Mg^*, then soaked with ppGpp, 
reveal electron density at the OTP pocket which is consistent with guanosine 5'-diphosphate 
2':3'-cyclic monophosphate (ppG2':3'p). Unlike ligand complexes of the synthetase 
involving IMP and GDP, the coordination of Mg'* here is octahedral with the side chain of 
Asp'" in the inner sphere of the cation. Interactions involving the 5'-pyrophosphoryl group 
and the base of GDP and the cyclic nucleotide are similar; however, cyclization of atoms 02' 
and 03' to the phosphoryl group stabilizes a different conformation of the ribosyl group of 
the stringent effector relative to that of GDP. The cyclic phosphoryl group interacts directly 
with the side chain of Lys"*' and indirectly through bridging water molecules with the side 
chains of Asn*'' and Arg^"'. The synthetase either directly facilitates the formation of the 
cyclic nucleotide or scavenges trace amounts of the cyclic nucleotide from solution. 
Regardless of its mode of generation, the cyclic nucleotide binds far more tightly to the active 
site than does ppGpp. The above raises the possibility of an in vivo mechanism, which 
modulates synthetase activity on the basis of relative concentrations of stringent effectors. 
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Introduction 
Escherichia coli and other bacteria which undergo nutritional stress, as for instance 
amino acid starvation, synthesize guanosine 5'-diphosphate 3'-diphosphate' (ppGpp) and 
guanosine 5'-triphosphate 3'-diphosphate (pppGpp). These nucleotides in turn dramatically 
influence a broad range of metabolic activities (stringent response), impairing the synthesis 
of DNA, RNA, proteins, nucleotides and phospholipids, and concomitantly stimulating 
amino acid biosynthesis (1). Evidently the stringent response stems from a severe shortfall, 
relative to the demands of ribosomal protein biosynthesis, in one or more of the 
aminoacylated tRNAs. During the stringent response in E. coli, pools of ATP and GTP 
decrease, but concentrations of pppGpp and ppGpp rise to millimolar levels. The reduction 
in the de novo synthesis of purine nucleotides putatively is a consequence of direct inhibition 
of adenylosuccinate synthetase and IMP dehydrogenase by ppGpp (2-4). 
Adenylosuccinate synthetase (IMPiL-aspartate ligase (GDP forming) E.C. 6.3.4.4) is 
an essential enzyme in Escherichia coli (2), catalyzing the first committed step in de novo 
biosyntheses of AMP: 
Mg--
IMP + L-aspartate + GTP < > adenylosuccinate + GDP + P, 
The catalytic mechanism is a two-step process (3—5): the formation of 6-phosporyl-IMP by 
nucleophilic attack of the 6-oxo group of IMP on the y-phosphoryl group of GTP, followed 
by a second nucleophilic displacement of the 6-phosphoryl group by aspartate to form 
adenylosuccinate. ppGpp potently inhibits the synthetase {Kfn ~ 50 |j.M; 6—8). The 
mechanism of inhibition by ppGpp, however, remains a point of controversy. ppGpp may 
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inhibit the synthetase by binding to an allosteric site, as suggested by its noncompetitive 
inhibition with respect to GTP (6,7), or by simply binding to the GTP pocket, as suggested 
by its competitive inhibition with respect to GTP in a different study (8). 
Reported here are crystal structures of adenylosuccinate synthetase from E. coli 
complexed with IMP, NOj", Mg**, hadacidin and guanosine 5'-diphosphate 2':3'-cyclic 
monophosphate (hereafter the ppG2':3"p complex) and with IMP, NOj", Mg^*, hadacidin. and 
GDP (hereafter the GDP complex). Hadacidin, a fermentation product of Penicillium 
frequentans (9). is a competitive inhibitor {Ki ~ 10"^ M) with respect to aspartate (10,11). 
Even though ppGpp was used as a ligand in crystal soaking buffers, the electron density in 
the guanine nucleotide pocket is consistent only with ppG2':3'p. Evidently, ppG2':3'p binds 
with much greater affinity to the synthetase than does ppGpp. Crystals either absorb a minor 
impurity of the cyclic nucleotide from solution or the synthetase itself transforms ppGpp to 
ppG2':3"p. Regardless of its mechanism of formation, the ppG2':3'p complex here 
represents the first structure of an effector of the stringent response with one of its target 
enzymes. 
Materials and Methods 
Purification of enzyme from E. coli— The synthetase was prepared as described 
previously fi-om a genetically engineered strain of E. coli (12). The enzyme was at least 95% 
pure on the basis of SDS-PAGE. 
Crystallization— Hadacidin was a generous gift of Drs. Fred Rudolph and Bruce 
Cooper, Department of Biochemistry and Cell Biology, Rice University. All other reagents 
came firom Sigma. Crystals were grown by the method of hanging drops under conditions 
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similar to those employed in previous work (13). For reasons provided below, acetate was 
excluded from the crystallization droplets, and in preparing crystals for ppGpp soaks, GDP 
was omitted as well. Droplets (total volume, 12 |iL) contained equal parts of an enzyme 
solution [HEPES (30 mM), IMP (4 mM), hadacidin (4 mM), GDP (either 0 mM or 4 mM) 
and protein (18 mg/ml) at pH 6.8] and a crystallization buffer [polyethylene glycol 8000 
(16% w/v), cacodylic acid/sodium cacodylate (100 mM, pH 6.5), magnesiimi nitrate (100 
mM)]. The pH of the droplets was 6.5. Wells contained 500 |iL of crystallization buffer. 
Crystals of approximately 0.8 mm in all dimensions belonging to the space group P3221 grew 
in about 1 week. The omission of GDP and/or acetate had no significant effect on unit cell 
parameters; the crystalline complexes here are isomophous to previously published ligand 
complexes of the synthetase. 
Preparation of ppG2 ':3 'p complex— ppGpp (preparation #33A) was prepared as 
described previously (14). The sample was checked for purity by thin layer chromatography, 
using polyethyleneimine plates and 1.5 M KH2PO4, pH 3.4 (14). Synthetase crystals, grown 
in the absence of guanine nucleotides, were exposed for 12 hours to a solution containing 
polyethylene glycol 8000 (18% w/v), cacodylic acid/sodium cacodylate (100 mM, pH 6.5), 
magnesium nitrate (100 mM), IMP (2 mM). hadacidin (2 mM), and ppGpp (1 mM). A 
soaked crystal then was transferred sequentially at 10 minute intervals to fresh solutions, 
which contained the components above along with glycerol at concentrations of 5, 10, 15, 20 
and 25% (v/v). Glycerol is a cryoprotectant of adenylosuccinate synthetase crystals. After 
passing through the glycerol equilibration steps, a single crystal was mounted and flash 
frozen to 100 K. 
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Thin layer chromatography— Possible degradation of ppGpp under conditions 
employed in soaking crystals was monitored by thin layer chromatography (14). Aliquots 
were taken at intervals of 2, 5, 12 and 36 hours from a solution containing Mg(N03)2 (100 
mM), hadacidin (2 mM), cacodylic acid/sodium cacodylate (100 mM, pH 6.5) and ppGpp (2 
mM). spotted on polyethyleneimine plates and developed in 1.5 M KH2PO4 (pH 3.4). 
Parallel time courses were run in the absence and presence of adenylosuccinate synthetase. 
GTP and ppGpp were used as standards in thin layer chromatography. The developed plates 
were inspected for UV-absorbing components. 
Data collection— Data from single crystals of the GDP complex and the ppG2':3'p 
complex were collected on a Siemens area detector at 100 K and were reduced by XENGEN 
(15). The data sets were above 97% complete to nominal resolutions (at which the average of 
I/<t(I) is 2) of 2.3 and 2.5 A for the GDP and ppG2':3'p complexes, respectively (Table 1). 
Model refinement— Starting phases were calculated from the GDP complex (13), 
omitting all ligands and solvent. Refinement procedures are as described previously (13). 
The ligand models were fit to omit electron density maps, followed by a cycle of refinement 
using XPLOR (16). Constants of force and geometry for the protein came from Engh & 
Huber (17), and those for hadacidin from Poland et al. (13). Refinement parameters for 
ppG2':3'p were based on those of GTP and the crystal structures of 2':3'-monophosphate 
nucleotides (18—20). In early rounds of refinement, models were heated to 2000 K and then 
cooled in steps of 25-300 K. In later rounds of the refinement, the systems were heated to 
1000 or 1500 K and cooled in steps of 10 K. After the slow-cooling protocol was complete 
(at 300 K), the models were subjected to 120 steps of conjugated gradient minimization. 
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followed by 20 steps of individual B-parameter refinement. Individual B-parameters were 
subject to the following restraints: nearest neighbor, main chain atoms, 1.5 A^; next-to-nearest 
neighbor, side chain atoms, 2.0 nearest neighbor, side chain atoms, 2.0 A^ and next-to-
nearest neighbor, side chain atoms, 2.5 A". Criteria for the addition of water molecules were 
identical to those of previous studies (5,13). 
Results 
Quality of the refined models—The method of Luzzati (21) indicates an uncertainty 
in coordinates of 0.30 A. The amino acid sequence used in refinement is identical to that 
reported previously (22,23). Results of data collection and refinement are in Table 1. A 
overview of the ppG2':3'p complex is in Figure 1, and a schematic of ppG2':3'p is in Figure 
2. Gin'" is the only serious violation of the Ramachandran plot as identified by PROCHECK 
(24). The conformation of Gln'° is enforced by its hydrogen bonding envirormient as 
described in previous work (22,23). The models have better sterochemistry than is typical for 
structures based upon data of comparable resolution. Thermal parameters vary in the GDP 
and ppG2':3'p complexes from 10 to 64 A"and 10 to 65 A*, respectively. The variation in 
thermal parameters as a function of residue is comparable to that of other structures of the 
ligated synthetase (5,13). Thermal parameters for individual ligands average to less than 30 
A" in each of the structures. Superposition of the GDP complex onto the ppG2':3'p complex 
results in a root-mean-square deviation of Ca coordinates of 0.3 A, comparable to the 
estimate of coordinate uncertainty. 
GDP complex— Conditions of crystallization for the GDP complex reported here 
differ from those of an earlier study (13) in the elimination of acetate from the crystallization 
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buffers. Acetate and GDP synergistically inhibit the synthetase, as does nitrate and GDP 
(25). Although the combination of GDP/nitrate exhibits greater synergism than GDP/acetate, 
the total concentration of acetate in the previous study was some 40-fold higher relative to 
the nitrate anion, hence the potential exists for substantial competition between nitrate and 
acetate for the putative y-phosphoryl pocket of GTP. The GDP complex presented here 
provides data to higher resolution relative to that of the previous GDP complex (2.3 as 
opposed to 2.8 A), and more significantly, the active site in the vicinity of the nitrate anion 
has stronger electron density and lower thermal parameters. The average distance of the six 
oxygen atoms nearest to the Mg^* (Table 2) in the present GDP complex has decreased by 
0.16 a relative to the former complex. Most significantly the distance between Mg^* and 
ODl of Asp'^ has fallen fi-om over 3.0 a in the GDP complex from acetate buffer to 2.7 a in 
the GDP complex without acetate. In the acetate-free buffer, the synthetase-bound Mg^* 
exhibits quasi-octahedral coordination, rather than the square pyramidal coordination of the 
ligated complex in acetate buffer. In addition Mis'" now interacts through a bridging water 
molecule with Glu"', whereas in the acetate buffer no water molecule is evident, and Mis'" 
exhibits an elevated set of thermal parameters. The elimination of acetate, then, results in the 
tighter coordination of Mg"* and a more ordered active site in the immediate vicinity of the y-
phosphoryl pocket. As the ppG2':3'p complex described below comes from an acetate-free 
buffer, the GDP complex without acetate reported here serves as a basis of comparison. 
ppG2 ':3 'p complex—The conformation of the synthetase in the ppG2':3'p complex 
is essentially identical to that of the GDP complex (Fig. 3, Table 2). Interactions of IMP, 
nitrate and hadacidin are unchanged from previous structures. Significant differences occur. 
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however, in the ligation of Mg^* and at the guanine nucleotide pocket. To within the 
uncertainty of the coordinates, Mg^* exhibits octahedral coordination, in contrast to the GDP 
complex, where it exhibits quasi-octahedral coordination. The oxygen atoms which define 
the equatorial plane of the Mg^" (one each from 5'-a- and 5'-P-phosphoryl groups of 
ppG2':3"p, from NO3", and from the N-formyl group of hadacidin) average to 2.1 A, as 
opposed to 2.3 A for the corresponding bonds in the GDP complex (Table 2). In the GDP 
complex. ODl of Asp 13 tightly hydrogen bonds (2.6 A) to N1 of IMP and is 2.7 A from the 
Mg*". In the ppG2':3'p complex, however, the distance between ODl of Asp'^ and N1 of 
IMP is 3.1 A, whereas the distance separating the Mg^"^ and ODl of Asp'^ is 2.5 A. Evidently, 
the synthetase coordinates Mg^^ more tightly in the ppG2':3'p complex than in the GDP 
complex; the tighter coordination occurring, however, at the expense of a weakened 
interaction between Asp'^ and N1 of IMP. The significance of the above to the mechanism of 
catalysis and inhibition of the synthetase is discussed below. 
The difference electron density in the guanine nucleotide pocket clearly indicates an 
analog of GDP (Fig. 4). Although electron density similar to that of the GDP complex is 
present for the base and 5'-pyrophosphoryl moieties, additional electron density extends from 
both the 2'- and 3'-hydroxyl groups of the stringent effector. The density can accommodate 
a single phosphoryl group, but not the pyrophosphoryl group expected at the 3' position. A 
difference map, based on observed data from the effector and GDP complexes, and calculated 
phase angles from the GDP complex, reveals a strong and well-defined peak of electron 
density in the vicinity of the 2'- and 3'-hydroxyl groups of GDP (Fig 3). The positive 
difference density overwhelms any negative difference density due to water molecules bound 
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to the 2'- and 3'-hydroxyls of GDP. Hence the bound nucleotide cannot be GDP. 
Furthermore, a 3'- (or 2'-) phosphoryl group cannot occupy the density without causing 
severe steric conflict with the remaining 2' (or 3'-) hydroxyl group of the ribose. The only 
acceptable fit to the electron density was provided by ppG2':3'p. Thermal parameters for the 
refined cyclic nucleotide are comparable to those of the surrounding protein, suggesting full 
occupancy of the ligand at the guanosine pocket. 
The synthetase recognizes the 5'-pyrophosphoryl group and the guanine base of GDP 
and ppG2':3'p in the same manner. Atom 06 of the cyclic nucleotide interacts with OG of 
Ser*''' and backbone amide 331. Endocyclic N1 and exocylic N2 of the base hydrogen bond 
with the side chain of Asp"^ The 5'-P-phosphoryl group of ppG2';3'p interacts with 
backbone amides 15, 16, and 17, the side chain of His^', and bound Mg*". The 5'-a-
phosphoryl group interacts with the Mg^*, backbone amide 42 and Arg^°^ The ribose moiety 
of ppG2':3"p, however, differs significantly in location and conformation relative to that of 
GDP (Fig 4). The 5'-a-phosphoryl group of ppG2':3'p rotates -120° around the torsion 
angle defined by atoms PB, OA, PA, and 05\ displacing the entire ribose moiety 
approximately 1 a toward loop 42-53. (Loop 42-53 undergoes a 9 a conformational change 
upon ligation of the synthetase active site). As a consequence, the cyclic 2':3'-phosphoryl 
group hydrogen bonds with the side chain of Lys'" (that side chain is disordered in the GDP 
complex), and forms water-mediated hydrogen bonds with the side chains of Asn*'' and 
Arg^"'. A water (Wat 505), common to all the ligated structures of the synthetase, hydrogen 
bonds to backbone carbonyl groups 44 and 417, and to atom 02' of GDP in the GDP 
complex. In the ppG2':3'p complex 02' is now 3.6 A fi-om the water molecule, bridging 
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only backbone carbonyls 44 and 417. The torsion angle 05'-C5'-C4'-C3' (y by convention) 
is -77° (-synclinal), the torsion angle 04'-Cl-N9-C4 (x by convention) is -118° (anti), both 
comparable to those of the GDP complex (y = -66° and x - -82°). The five member ring 
(02'-Pl-03'-C3'-C2') is nearly planar, and its angles, bond lengths, ribose ring pucker (C2'-
endo. C3'-exo) are comparable to those of cyclic nucleotides, observed in high resolution 
crystal structures (19.20). 
Thin layer chromatography—ppG2':3'p is putatively an intermediate in the 
degradation of ppGpp (26). ppGpp is acid and alkali-labile, but relatively stable at neutral 
pH. The stability of ppGpp was monitored by thin layer chromatography in solutions of 
composition indicated above. No detectable hydrolysis product of ppGpp appeared up to 32 
hours either in the presence or absence of the synthetase 
Discussion 
Under the conditions of our crystallographic studies ppGpp does not undergo 
significant hydrolysis. Two possibilities, then, can account for the appearance of ppG2':3'p 
in the guanine pocket of the synthetase: either the crystalline synthetase scavenges a minor 
(and undetectable) impurity of the cyclic nucleotide from our sample of ppGpp or the 
synthetase itself facilitates the conversion of ppGpp to the cyclic nucleotide. As no build-up 
of the cyclic nucleotide was observed in the presence of the synthetase, the putative enzyme-
mediated process must occur without appreciable turnover. For the latter scenario, ppGpp 
must bind to the guanine pocket and undergo cyclization, producing an inhibitor so potent 
that it does not readily dissociate from the synthetase. 
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As a means of better understanding a possible enzyme-mediated mechanism, one can 
model a transition state complex for the cyclization of ppGpp in the guanine nucleotide 
pocket (Fig. 5). Mg^" (total concentration of 100 mM) must be associated with the 3'-
pyrophosphoryl group of ppGpp under the conditions of crystal soaks. The water molecule, 
which bridges backbone carbonyls 44 and 417 and hydrogen bonds with the 2'-hydroxyI of 
GDP (Table 2), may act as a weak catalytic base and abstract a proton from the 2'-0H of 
ribose (Fig. 5). The activated 02' atom then attacks the 3'-a-phosphoryl group, displacing 
the 3'-P-phosphoryl group. The side chain of Lys^', as well as the Mg^* associated with the 
3'-pyrophosphoryl group, would stabilize the development of negative charge on the leaving 
group and/or the transition state. A lysyl side chains in an analogous positions are critical to 
the catalytic function of adenylate kinase and GTPases in general. 
Regardless of its mode of formation, ppG2':3'p must bind at least 200-fold more 
tightly than does ppGpp to the active site of the synthetase, assuming the cyclic nucleotide is 
5% of the concentration of ppGpp in soaking solutions, and that the for ppGpp is 50 |iM. 
The estimated for ppG2':3'p (~10'' M) compares favorably to the tightest known 
inhibitors of the synthetase, alanosyl-AICOR [~I0'' M, (27)] and hydantocidin 5"-phosphate 
[^10"® M. (28)]. The enhanced binding of ppG2':3'p may arise from three sources: (i) 
Cyclization of the 2'- and 3'-hydroxyls of the ribose reduces conformational freedom of the 
nucleotide and hence reduces the entropic penalty associated with ligand binding, (ii) The 
2':3'-phosphoryl group provides additional opportunities for strong hydrogen bonds with the 
synthetase, (iii) The active site Mg^^ has octahedral coordination, whereas in GDP 
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complexes its coordination is square pyramidal (13) or quasi octahedral (see above). In fact, 
an octahedrally coordinated metal cation appears as well in the complex of the tight-binding 
inhibitor hydantocidin 5'-phosphate (29). Asp'^ interacts directly with IMP in GDP 
complexes (see above), and evidently in the absence of an IMP-Asp'^ interaction [as in the 
hydantocidin 5"-phosphate complex (29)] or a weakened IMP-Asp'^ interaction (as here in 
the ppG2':3'p complex), Asp'^ favors direct coordination to the Mg^^. Octahedral 
coordination of the active site Mg^*, then, may be a hallmark of tight-binding inhibitors of the 
synthetase. Such inhibitors are of potential significance in chemotherapy and the 
development of herbicides (27,28). 
The presence of the cyclic nucleotide at the guanine nucleotide pocket is consistent 
with simple competitive inhibition with respect to OTP (8), but does not exclude an 
additional binding site for ppGpp elsewhere on the synthetase (6,7). The synthetase is 
modified covalently and inactivated by pyridoxal phosphate (30) and guanosine-5"-<9-[S-(4-
bromo-2,3-dioxobutyI) thiophosphate] (31) at Lys'"*® and Arg'^^, respectively. IMP protects 
against inactivation. Under the conditions used in the covalent modification reactions, the 
synthetase is probably a monomer. The modifying reagents probably are targeted by their 
phosphoryl group to a cluster of basic residues (Lysl40, Argl43. and Argl47), which are 
exposed putatvely in synthetase monomers, but buried between monomers in the synthetase 
dimer. IMP putatively protects this cluster of basic residues by stabilizing the synthetase 
dimer. Presumably, a ligand which prevents dimerization of the synthetase, will elevate the 
of IMP and appear kinetically as a competitive inhibitor of IMP and a noncompetitive 
inhibitor of GTP. If so, then initial rate kinetics using a fixed concentration of IMP near its 
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and variable GTP and ppGpp concentrations should best reveal this kind of 
noncompetitive inhibition. Stayton and Froram (8) employed precisely these conditions, but 
observed only competitive inhibition with respect to GTP. 
Potent inhibition of adenylosuccinate synthetase in vivo typically impedes growth of 
the organism. The pur A', E. coli cell line grows poorly, even in rich medium. Hydantocidin 
(which is transformed in plants to the tight-binding synthetase inhibitor, hydantocidin 5'-
phosphate) is a potent herbicide (27). Alanosyl-AICOR and hadacidin are antibiotics (9,28), 
the later having only the synthetase as a known target. Hence if the stringent response is 
ultimately a coordinated attempt by E. coli to limit its own growth under unfavorable 
conditions, then the synthetase is an appropriate target. 
Even though ppGpp is an effective inhibitor of the synthetase at its physiological 
concentration during the stringent response, other effectors (pppGpp and ppG2':3'p) may 
significantly influence synthetase activity. The transformation of ppGpp into ppG2':3'p, 
perhaps at the active site of the synthetase, suggests a parallel and more potent mechanism of 
inhibition, which may be temporally distinct from the inhibition by ppGpp. pppGpp, 
putatively the first nucleotide generated during the stringent response, could be an inhibitor 
of the synthetase, its S'-y-phosphoryl group being transferred to IMP while the cyclization 
reaction occurs independently at the guanine pocket. The result would be an active site 
complex of 6-phosphoryl IMP and ppG2':3'p. The combination of the synthetase with GTP 
and 6-thio-IMP has resulted in the formation of a stable complex of 6-thiophosphoryl-IMP at 
the active site (5). Furthermore, the combination of IMP and GTP leads to the analogous 6-
phosphoryl-IMP complex (Choe, J. -Y., Poland, B. W., Fromm, H. J. & Honzatko, R. B., 
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unpublished). Hence, the double chemical transformation of pppGpp at the active site of the 
synthetase is well within the realm of possibility. Alternatively if pppGpp is a simple 
substrate of the synthetase, then in vivo inhibition would depend on the relative 
concentrations and affinity constants of pppGpp and ppGpp, as well as the concentration of 
the cyclic effector. The inhibition of the E. coli synthetase by stringent effectors then may be 
far more complex than the competition of ppGpp for the active site. 
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Table 1. Refinement Statistics for adenylosuccinate synthetase 
ppG2':3'p GDP 
complex complex 
Resolution (A) 2.5 2.3 
Number of measurements 134,672 154,316 
Number of unique reflections 23,427 29,374 
Completeness of data set (%) 99 97 
Completeness of data in the last resolution shell (%) 99 (2.36-2.60 A) 93 (2.18-2.36 A) 
9.2 8.5 
Number of reflections in refmement*" 15,550 14,929 
Number of atoms' 5.220 5,386 
Number of solvent sites 354 410 
y?-factor^ 0.185 0.165 
/?-free' 0.25 0.24 
Refinement resolution (A) 5 to 2.5 5 to 2.3 
Mean B (A*) for protein 25 24 
rms deviations 
Bond lengths (A) 0.016 0.012 
Bond angles (deg.) 1.61 1.78 
Dihedral 24.6 24.4 
Improper dihedral angles (deg.) 1.4 1.3 
' = S,r,|lj, - <1,>1/1,2(1,,, where i runs over multiple observations of the same intensity, and 
j runs over all crystallographically unique intensities. 
^ All data in the resolution ranges indicated. 
' Includes hydrogens linked to polar atoms. 
- /^-factor = I - |F^J1 / S |F^|, \F^\ > 0. 
' /?-free based upon 10% of the data randomly culled and not used in the refinement. 
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Table 2. Selected contacts involving ligands of the GDP and ppG2\-3'p complexes 
ppG2" 3'p GDP 
Ligand atom Contact atom Distance (A) Distance (A) 
IMP 
06 N3 Nitrate 2.95 2.81 
NE2 Gln224 2.75 2.74 
N1 ODl AspI3 3.07 2.63 
N7 NE2 Gln224 3.35 3 19 
02- NH2 Arg303 2.57 2 98 
O Val273 2.71 2 73 
OlA NHI Argl43* 2.91 3 20 
02A OGI Thr239 2.72 2 67 
ND2 Asii38 3 11 3 32 
03A N Thrl29 2.91 266 
OGI •nirI29 2.86 2.64 
Metal 
Mg"' 02 Nitrate 2.30 2.48 
02B GDP 2.09 2.08 
OlA GDP 2.19 2.17 
ODI Aspl3 2.47 2 73 
0 Gly40 204 1 95 
0 Hadacidin 208 : 19 
Hadacidin 
0 Mg^* 2.08 2 19 
OB 0D2 AspI3 2.56 2.73 
ODl Aspl3 3 06 3 11 
NH2 Ar^OS 3.00 2.76 
NE Arg305 3.25 3 12 
DDI NH2 Arg303 2.88 2.71 
OGI Thr301 2.78 2.85 
0D2 OGI Thr30I 2.89 299 
N Thr30I 2.79 2 88 
N Thr300 3.10 3 20 
Nitrate 
01 N Gta224 2.72 2.61 
NZ Lysl6 3,11 3 27 
02 Mr* 2.3 248 
N Gly40 2.82 273 
03 NZ Lysl6 2 54 2.56 
N Aspl3 2 94 3 10 
N3 06 IMP 2 95 2.81 
ppG2' 3 p GDP 
NI ODl Asp333 3.15 2.81 
N2 0D2 Asp333 2.80 2 78 
06 OG Ser414 2 52 2 52 
N Gly416 3 34 3 22 
N Lys331 3 10 3.20 
02- O Wat605 3.50 2 53 
OlA NH2 Arg30S 3.03 3 14 
Mg'- 2.29 2 17 
OS- N Thr42 3.40 -
OS- NHI Arg305 - 3 80 
02A NHI Arg305 3.21 -
02A* N Thr42 — 3.26 
OIB N GIyl7 2.86 2.77 
NDl His4I 2.97 2.85 
028 Mg^- 2.09 208 
NDl His4I 3.36 2.92 
03B N LysI6 2.95 2 74 
N GlylS 3 06 3.03 
N Glul4 3.32 3.47 
04' NZ Lys331 3.43 3.11 
O i l  NZ Lys49 2.65 
OW Wal587 2.75 
CG Thr42 2.89 
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Figure 1. Overview of the ppG2':3'p complex of the synthetase. Stereoview, drawn 
with MOLSCRIPT (34), of a single monomer of the synthetase dimer showing 
IMP, Mg^* and ppG2':3'p as ball-and-stick models. 
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Figure 2. Schematic of ppG2':3'p showing atom labels. 
Nitrate Nitrate 
His41 
Arg305 
Glu29 
Wal587 at587 
Ser414 Ser414 
Pro417 Pro417 
Asp333 Asp333 
00 
Figure 3. Stereoview of interactions between ppG2':3'p and the active site. Ligands [only 
hadacidin (Had), nitrate, ppG2':3'p, and Mg^' are shown] are drawn with bold lines. 
Donor-acceptor interactions (corresponding distances listed in Table 2) are presented 
with dashed lines. 
Figure 4. A. Stereoview of electron density associated with ligands in the ppG2^3'p 
complex. The electron density, contoured at 2.5 a using a cut off radius of 0.9 A, 
comes from a ligand-excised omit map. ppG2':3'p and other active site ligands are 
represented with bold lines. 
Figure 4. B. Difference electron density based on phases from the GDP complex and 
Fourier coefficients from the ppG2':3'p and GDP complexes. The contour level is 
1.5 a, and reveals only residual electron density in the ppG2':3'p complex that has no 
counterpart in the GDP complex. The GDP molecule is represented with bold lines 
and the ppG2':3'p molecule with fine lines. 
Arg305 ArgSOS 
Gu296 Glu296 
;^at863 
Asn295v / i\ 
Wat864^'^ ^ ' 
sn295 
Wat864 Thr42 
Lys331 Lys331 
Wateos at605 
ro417 ro417 
00 
Figure 5. Stereovicw of a model for (he putative transition state in the conversion of 
ppGpp into ppG2*:3'p at the active site of the synthetase. Ligands [hadacidin (Had), nitrate, 
Mg^* and the nucleotide transition state] are drawn with bold lines. Bold, dashed lines represent 
the geometric relationship of the attacking nucleophile and leaving group with respect to the 3'-
a-phosphoryl group. Possible donor-acceptor interactions are represented with dashed lines. A 
second Mg^*, which could interact with the 3'-pyrophosphoryl group of the nucleotide, is not 
shown. 
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CHAPTER 5. GENERAL CONCLUSIONS 
In this dissertation, the basic questions concerning the effects of the divalent metal 
cations, the ligand induced conformational changes, and the inhibitory properties of stringent 
effectors for the adenylosuccinate synthetase from Escherichia coli were explored using x-
ray crystallographic techniques. Metal cations, ligand-induced conformational transitions and 
metabolic effectors significantly influence the catalytic potential of the synthetase. The Mg^*. 
Mn-*. or Ca*^ bind to the same site, coordinating a-, P-, and y-phosphoryl groups of GTP. 
The level of catalysis supported by each cation is linked to its influence on the basicity of 
Asp 13, a residue which abstracts the proton from N1 of IMP. Zn^*, a potent mhibitor of the 
synthetase, coordinates the P- and y-phosphoryl groups of GTP and His41, stabilizing a dead­
end complex of the synthetase. Although G-protein and the synthetase have remarkable 
structural similarity in the GTP binding pocket, the role of metal cations in the synthetase and 
the related G-proteins contrasts sharply. Compared to G-protein, our data suggest that the 
synthetase scarifies its binding affinity for its substrates to gain higher catalytic potential by 
way of choosing a unique metal binding site. Efforts to locate a low affinity site for Mg"' 
resulted in the first crystalline complex of the synthetase with L-aspartate. The L-aspartate 
complex does not reveal a secondary site for Mg"*, but suggests a mechanism whereby 
binding energy, derived from interactions of the a-carboxylate of L-aspartate, compress the 
a-amino group of that substrate into the base moiety IMP. Hydrogen bond formation 
between the 5'-phosphate of IMP and Asn38 drives large conformational changes as far as 30 
A away. Indeed the 5'-phosphoryl group of IMP, even though it is not directly involved in 
catalysis, is as important to the stability of the transition state as essential protein side chains 
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directly involved with catalysis. The conformational changes of loop-40 and loop-400 are 
driven by the IMP binding, and are associated with the events of the rupture of the salt-
linkage between the side chain of His41 and the side chain of Asp21, and the formation of 
two salt-linkages of the peptide side chains between His41 and Glu221 and between Asp21 
and Arg419. GTP can bind the synthetase either in active or inactive confirmations, 
depending on the existence of IMP. Guanosine 5'-diphosphate 3'-diphosphate (ppGpp), a 
pleiotropic effector of the stringent response, potently inhibits the synthetase. The 
combination of ppGpp with crystals of the synthetase, however, reveals guanosine 5'-
diphosphate 2';3'-cyclic monophosphate, at the GTP pocket. The sythetase itself may 
catalyze the formation of the cyclic inhibitor, leading to a tight ligand-enzyme complex. In 
fact, stringent effectors could modulate synthetase activity by way of several mechanisms, 
including the formation of a 6-phosphoryl-IMP and cyclic nucleotide complex. 
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